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INTRODUCTION 
Hypertensive disorders complicate 5 to 10% of all pregnancies and together it 
forms one member of the deadly triad, along with haemorrhage and infection, which 
contribute greatly to maternal morbidity and mortality rates1. Preeclampsia is a 
multisystem disorder and represents a major threat to foetus and mother when it 
emerges2. Apart from its most dreaded complication of progressing into eclampsia, 
preeclampsia by itself can result in substantial perinatal and maternal morbidity. 
It has been reported that the major cause of both maternal and fetal morbidity 
and mortality is preeclampsia (Bringman et al., 2006). It has been estimated that more 
than 14% (58,000) of maternal deaths/year worldwide are due to eclampsia and 
preeclampsia, but in developed countries, it mainly affects fetus3. The incidence of 
preterm birth due to preeclampsia is around 15%4. 
The trophoblast normally invades the decidual portion of the spiral arteries 
beginning by eighth week and this invasion is usually complete by the thirteenth 
week. After this time the second stage of spiral artery invasion starts in, whereby the 
myometrial portion of the spiral arteries are similarly invaded by the trophoblast. This 
is usually completed by 18 to 19 weeks but may be delayed upto 22 to 24 weeks. In 
an overwhelming majority of preeclamptics, this transformation does not occur in the 
spiral artery bed leading to increased resistance to flow into the intervillous space. 
The method of choice to indirectly monitor the status of spiral artery bed is by uterine 
artery waveform4. Increased uterine artery velocimetry determined by Doppler 
ultrasound in the first and middle trimester should provide indirect evidence of this 
process and thus serve as a predictive test for preeclampsia. Performing uterine artery 
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Doppler studies at 23- 26 weeks’ gestation instead of 19- 22 weeks’ gestation 
increases the predictive value for adverse pregnancy outcomes6. 
In the non-pregnant state uterine artery Doppler shows low peak flow velocity 
and early diastolic notch. At 18 to 20 weeks, there is high flow with no diastolic 
notch. Impaired uterine artery flow is considered when there are high resistance 
uteroplacental waveforms and the presence of diastolic notch which is the 
manifestation of arterial vessel tone and represents elasticity of the vessel and 
vasospasm. It disappears in the second trimester. A high resistance pattern is 
associated with higher rate of pregnancy complication with a 70% chance of 
developing protienuric hypertension and a 30% chance of a coexisting small for 
gestational age fetus7. Although several studies have used uterine artery doppler as a 
screening tool for preeclampsia and fetal growth restriction in unselected population, 
a debate continues as to its value. Varying sensitivities are obtained depending on the 
type of Doppler used, the sampling site, the definition of abnormal uterine artery 
resistance, gestational age of assessment and different end points7.This study helps to 
evaluate the usefulness of first and midtrimester uterine artery Doppler study in both 
high risk and low risk women to predict preeclampsia. 
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AIMS AND OBJECTIVES OF THE STUDY 
• To evaluate the usefulness of uterine artery doppler screening in first and mid 
trimester to predict the risk for preeclampsia and IUGR. 
• To know the sensitivity and specificity of uterine artery Doppler 
indices(Pulsatility index and diastolic notching) in prediction of preeclampsia 
in pregnant women 
• To know the outcome of pregnancy and its relation with the uterine artery 
Doppler indices. 
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REVIEW OF LITERATURE 
History 
The interesting history of hypertensive disorders in pregnancy is probably as 
old as human existence. From ancient times, convulsions were found in pregnancy 
towards term, during labour and postpartum. Indian Atharvaveda and Sushruta both 
mention about preeclampsia and eclampsia. Hippocrates had also recognised the 
grave prognosis of convulsions occurring during childbirth and differentiated it from 
epilepsy. 
The disorder was first recognised almost 2000 years ago. Celsus described 
pregnant women with seizures that abated with delivery. This disorder was termed 
eclampsia and for two thousand years was considered a pregnancy specific seizure 
disorder. 
In the late 17th century, obstetrician Francis Mauericeua identified 
preeclampsia as a specific disorder related to pregnancy. He observed that the 
convulsions often cease after delivery and recommended prompt termination of 
pregnancy as the best treatment. 
In the late 1800s the association of initial protienuria and later increased blood 
pressure with eclampsia was recognised. It was also noted that women with increased 
blood pressure and urinary protein antedated the seizures. From this came the term 
preeclampsia.. 
Later Young in 1974 attributed preeclampsia to the placental toxin that was 
elaborated in the area of red infarct in the placenta and termed preeclampsia as 
‘Toxemia of pregnancy’. JCM Browne and Veale in 1953 showed the presence of 
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placental ischemia in pregnancy induced hypertension. About 10 years ago, Roberts et 
al formerly proposed that maternal endothelial dysfunction is the key event resulting 
in the diverse clinical manifestations of preeclampsia9. 
 The first pulsed wave Doppler equipment was developed by Seattle research 
team in 1966. Outstanding contribution was made by Donand Baker, Dennis Watkins 
and John Reid. Duplex Doppler techniques allowed the ultrasound operator to 
determine deep fetal and maternal circulation could be studied. 
Campbell, a pioneer and consistent leading light in obstetric sonography, was 
the first to explore the potential of uterine artery waveforms in predicting 
preeclampsia. Initially, he and his colleagues used a handheld continuous wave 
Doppler device to find the characteristic waveform at about 18weeks. Although his 
initial results were encouraging with regard to its predictive ability for preeclampsia, 
others initially could not repeat his results. However, it became clear that the 
continuous wave Doppler did not allow an ability to pinpoint the sampling site (as 
with pulse wave Doppler), and, most importantly, a good 25% of patients who 
initially have abnormal Doppler at 18weeks’ do convert over to a normal waveform 
by 24weeks’. These late converters do not have the same predilection for 
preeclampsia as those whose waveforms remain abnormal at 24weeks10. 
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HYPERTENSIVE DISORDERS IN PREGNANGY 
The term ‘Hypertension in Pregnancy is commonly used to describe a wide 
spectrum of patients who may have only mild elevations in blood pressure (BP)or 
severe hypertension with various organ dysfunctions. 
 
Incidence 
Hypertensive disorders complicate 5 - 10 percent of all pregnancies. In India, 
incidence is 5-15%11, incidence being more in nullipara, around 15% and in 
multiparas around 10%9,11. The incidences of the various types of hypertensive 
disorders in pregnancy are given in Table 1. 
 
TABLE-1 . Incidence of Hypertensive disorders in Pregnancy. 
Gestational hypertension 
 
5% 
Preeclampsia 
 
5-7% 
Eclampsia 
 
0.5-2% 
Preeclampsia superimposed on chronic 
hypertension 
 
25% 
Chronic hypertension 
 
1-2% 
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Classification of hypertensive disorders in pregnancy 
The working group classification of hypertensive disorders complicating pregnancy 
describes four types of hypertensive disease1. 
• Gestational hypertension—formerly termed Pregnancy-induced Hypertension.  
• Preeclampsia and Eclampsia syndrome 
• Preeclampsia syndrome superimposed on chronic hypertension 
• Chronic hypertension 
Definitions(National high blood pressure education program working group 
report on high blood pressure in pregnancy 2000)1. 
Gestational hypertension: 
 Systolic BP 140 or diastolic BP 90 mm Hg for the first time during pregnancy  
 No proteinuria  
 Blood pressure returns to normal before 12 weeks postpartum  
 Final diagnosis made only postpartum  
 May have other signs or symptoms of preeclampsia. For example, epigastric 
discomfort or thrombocytopenia 
 
Preeclampsia: 
 Minimum criteria: 
Blood pressure 140/90 mm Hg after 20 weeks' gestation  
Proteinuria 300 mg/24 hours or 1+ dipstick 
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 Increased certainty of preeclampsia: 
Blood pressure 160/110 mm Hg  
Proteinuria 2.0 g/24 hours or 2+ dipstick  
Serum creatinine >1.20 mg/dl unless known to be previously elevated  
Microangiopathichemolysis—increased LDH 
Platelets < 1,00,000/l  
Elevated serum transaminase levels—ALT or AST 
Persistent headache or other cerebral or visual disturbance  
Persistent epigastric pain 
Eclampsia: 
 Seizures that cannot be attributed to other causes in a woman with preeclampsia
 
Superimposed preeclampsia on chronic hypertension: 
 New-onset proteinuria of 300 mg/24 hours in hypertensive women but no 
proteinuria before 20 weeks' gestation  
 A sudden increase in proteinuria or blood pressure or platelet count < 100,000/l in 
women with hypertension and proteinuria before 20 weeks' gestation 
Chronic hypertension: 
 Blood pressure 140/90 mm Hg before pregnancy or diagnosed before 20 
weeks' gestation not attributable to gestational trophoblastic disease or 
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 Hypertension first diagnosed after 20 weeks' gestation and persistent after 12 
weeks postpartum 
Risk factors for preeclampsia13, 14 
 Pregnancy associated factors 
• Chromosomal abnormalities 
• Hydatidiform mole 
• Hydropsfetalis 
• Multifetal pregnancy 
• Structural congenital anomalies 
 Maternal specific factors 
• Age less than 20 years 
• Age greater than 35 years 
• Nulliparity 
• Preeclampsia in a previous pregnancy 
• Family history of preeclampsia 
• Specific medical conditions: gestational diabetes, type 1 diabetes, obesity, 
chronic hypertension, renal disease, thrombophilias 
FETAL FEATURES OF PRE-ECLAMPSIA 
 
Ultrasound features of pre-eclampsia demonstrated in the fetus include: 
 
• Fetal growth restriction 
• Changes in amniotic fluid volume (oligohydramnios) 
• Abnormal Doppler waveforms 
 
Severe growth restriction results in premature delivery, with the related risk of 
long term respiratory and neuro developmental problems. There is an increased 
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perinatal mortality, particularly in very low birth weight infants. Intrauterine 
hypoxia which can occur in FGR may contribute to the risk for cerebral palsy. If 
central redistribution of blood flow in the fetus occurs, there can be ischemia of 
the gut leading to necrotizing enterocolitis (Loughna 2006:266). 
 
MATERNALCOMPLICATIONS 
 
Maternal complications of pre-eclampsia include: 
• Placental abruption (1-4%) 
• HELLP syndrome (10-20%) 
• Pulmonary oedema (2-5%) 
• Acute renal failure (1-5%) 
• Eclampsia (<1%) 
• Death 
 
Death associated with pre-eclampsia-eclampsia may be due to cerebrovascular 
events, renal or hepatic failure or HELLP syndrome.  
  
 NEONATALCOMPLICATIONS 
 
Evidence suggests that pre-eclampsia often coexists with FGR 
(Papageorghiouetal.,2008: 367). The report on Confidential Enquiry into 
Stillbirths and Deaths in Infancy cites one in six stillbirths that occur in 
pregnancies complicated by maternal hypertension. 
Fetal complications of preeclampsia include: 
 
• Preterm delivery (15-67%) 
• FGR (10-25%) 
• Hypoxia-neurologic injury (<1%) 
• Perinatal death (1-2%) 
 
 
11 
 
Theories for causation of preeclampsia 
DISEASE OF THEORIES WITHOUT ANY CAUSE15. Writings describing 
eclampsia have been traced as far back as 2200 BC (Lindheimer and colleagues, 
1999).It is not surprising that a number of mechanisms have been proposed to explain 
its causes. Many of the absurd and especially the dangerous thankfully have been 
discarded. According to Sibai (2003), currently plausible potential causes include the 
following1. 
• Abnormal trophoblastic invasion of uterine vessels 
• Immunological factors 
• Endothelial cell activation  
• Genetic influences 
• Dietary deficiencies 
Abnormal trophoblastic invasion of uterine vessels 
Preeclampsia is characterised by incomplete trophoblastic invasion1, 15. With shallow 
invasion, only the decidual vessels that become lined with endovascular trophoblasts. 
As a result of which the deeper myometrial arterioles do not lose their endothelial 
lining and musculoelastic tissue, and their external diameter is only half that of 
vessels in normal placenta. In the process of pseudovasculogenesis or vascular 
mimicry, the cytotrophoblast differentiates from an epithelial phenotype to an 
endothelial phenotype, as shown in Figure1. 
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FIGURE-1.Normal and abnormal trophoblastic invasion of uterine vessels. 
 
 
 
 
 
 
 
 
De wolf and co-workers (1980) observed that early preeclamptic changes included 
endothelial damage, insudation of plasma constituents into vessel walls, proliferation 
of myointimal cells, medial necrosis and lipid accumulation first in myointimal cells 
and later in macrophages. Such lipid laden cells and associated findings have been 
termed Atherosis. Aneurismal dilatations develop in the vessels affected by atherosis 
and are frequently found in spiral arterioles which have failed to undergo normal 
adaptation. Luminal narrowing in the spiral arteriolar by atherosis causes diminished 
which eventually leads to the preeclampsia syndrome1, 16. 
IMMUNOLOGICAL FACTORS 
This can be explained by 
 Immune dysregulation: During pregnancy, there is immune tolerance to paternal 
derived placental and fetal antigens. Loss of this tolerance or probably its 
dysregulation is another theory cited for preeclampsia. The microscopic changes 
at the maternal placental interface are suggestive of acute graft rejection. The risk 
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of preeclampsia is enhanced in circumstances where formation of blocking 
antibodies to placental antigenic sites provided by the placenta is unusually great 
compared with the amount of antibody, as with multiple fetuses.  
 Immune maladaptation: Dekker and Sibai (1998) have reviewed the possible 
role of immune maladaptation in the pathophysiology of preeclampsia. In women 
destined to develop preeclampsia at early second trimester, have a lower 
proportion of helper T cells compared with that of women who remain 
normotensive. This th2 dominance with th1/th2 imbalance may be mediated by 
adenosine which is found in higher serum levels in preeclamptic compared with 
normotensive women. These helper t lymphocytes secrete specific cytokines that 
promote implantation, and their dysfunction may favour preeclampsia1, 16. 
Endothelial cell activation 
Inflammatory changes are thought to bea continuation of stage 1 changes caused by 
defective placentation. In response to ischemic changes certain placental factors 
released which causes, a cascade of events in which antiangiogenic factors and other 
inflammatory mediators provoke endothelial cell injury. 
Cytokines such as tumor necrosis factor and the interleukins contribute to the 
oxidative stress associated with preeclampsia. Oxidative stress leads to formation of 
free radicals which lead to formation of self-propagating lipid peroxides which in turn 
generate highly toxic radicals that injure endothelial cells, modify their nitric oxide 
production and interfere with prostaglandin balance. 
Angiogenic imbalance is due to the excessive amount of anti angiogenic factors like 
soluble endoglin(seng) and placental soluble fms like tyrosine kinase 1(sflt-1). The 
production of these factors is stimulated by the hypoxia at the uteroplacental interface. 
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Sflt-1 antagonises vascular endothelial growth factor (vegf) and placental growth 
factor (plgf), blocking the induction of nitric oxide and vasodilator prostacyclins in 
the endothelial cells as shown in Figure2. 
FIGURE- 2.Endothelial dysfunction in preeclampsia. 
 
 
 
 
 
 
 
 
 
A rise in sflt-1 levels and a corresponding drop in vegf and plgf levels can be 
measured 5 to 6 weeks before the onset of clinical preeclampsia and have been 
established as predictors for the subsequent development of preeclampsia1, 17. 
Genetic factors 
Preeclampsia is a multifactorial, polygenic disorder. Ward and Lindheimer (2009) cite 
an increased risk for preeclampsia in a patient with family history of preeclampsia in a 
first degree relative1. The below Table 2 represents the incidence of preeclampsia in a 
given patient if the family history of preeclampsia is found to be positive. 
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TABLE - 2.Incident risk if patient’s first degree relative is preeclamptic. 
Relatives with history of preeclampsia Incident risk in the patient 
Mother 20-40% 
Sisters 11-37% 
Twin sister 
Heterozygous 
Monozygous 
 
22-47% 
60% 
 
This hereditary predisposition a result of inherited gene which control enzymatic and 
metabolic functions throughout every organ system. Thus the clinical manifestation in 
any given woman with the preeclamptic syndrome will occupy a spectrum as 
discussed under the two stage concept. Around 70 genes have been identified for their 
probable association. Polymorphisms of the genes for tnf, lymphotoxin and 
interleukin-1 have been studied with varying results. 
Because of heterogeneity of preeclampsia syndrome, and other genetic and 
environmental factors that interact with its complex phenotypic expression, it is 
doubtful that any one gene will be found responsible1. 
Genes with Possible Associations with Preeclampsia Syndrome are 
• F5(leiden) Factor VLeiden 
• AGT (M235T) Angiotensinogen 
• NOS3 (Glu 298 Asp) Endothelial nitric oxide 
• F2 (G20210A) Prothrombin (factor II) 
• ACE (I/DatIntron 16) Angiotensin-converting enzyme 
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Nutritional factors 
First it was postulated that lowered serum magnesium levels during pregnancy might 
predispose to seizures during pregnancy in susceptible women, such as those with a 
tendency toward epilepsy (Suter and Klingman, 1957)8.  
An inverse relationship between calcium intake and hypertensive disorders of 
pregnancy was first described in 1980. Epidemiological and clinical studies led to the 
hypothesis that an increase in calcium intake during pregnancy might reduce the 
incidence of high blood pressure and preeclampsia among women with low dietary 
calcium. An association has been found between preeclampsia and hypocalciuria, low 
urine calcium to creatinine ratio, hypocalcaemia, low plasma and high membranous 
calcium, low dietary milk intake. The lowering of serum calcium and the increase of 
intracellular calcium may cause an elevation of blood pressure in preeclamptic 
mothers.  
PATHOGENESIS 
Vasospasm: The concept of vasospasm was advanced by Volhard (1918) based on 
direct observations of small blood vessels in the nail beds, ocular fundi, and bulbar 
conjunctivae. It was also proved from histological changes seen in various affected 
organs. Vascular constriction causes resistance and subsequent hypertension. At the 
same time, endothelial cell damage causes interstitial leakage through which blood 
constituents, including platelets and fibrinogen, are deposited subendothelially. With 
diminished blood flow because of maldistribution, ischemia of surrounding tissues 
would lead to necrosis, haemorrhage and other end organ disturbances characteristic 
of the syndrome. Ironically, vasospasm may be worse in women with preeclampsia 
than in those with the hellp syndrome1, 16, and 17. 
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Endothelial cell activation: Over the past two decades, endothelial cell activation has 
become the centrepiece in the contemporary understanding of the pathogenesis of 
preeclampsia. Unknown factors, likely from the placenta are secreted into the 
maternal circulation and provoke activation and dysfunction of the vascular 
endothelium. The clinical syndrome of preeclampsia is thought to result from this 
widespread endothelial cell changes. In addition to micro particles, Grundmann and 
associates have reported that circulating endothelial cell (CEG) levels are significantly 
elevated four fold in the peripheral blood of preeclamptic women1, 16, and 17. 
The function of intact endothelium 
 It primarily takes part in hemostasis and blunts the response of the vascular 
smooth muscle to vasospasm. 
 It also blunts the response of vascular smooth muscle to agonists by releasing 
nitric oxide. 
 The anticoagulant property is exerted by preventing blood clot formation. 
 It causes fibrinolysis which is mediated through plasminogen activators. 
Damaged or activated endothelial cells secrete substances that promote coagulation 
and increase the sensitivity to vasopressors. Further evidence of endothelial activation 
includes the characteristic changes in glomerular capillary endothelial morphology, 
increased capillary permeability, and elevated blood concentrations of substances 
associated with such activation17. 
Role of vasoactive agents:  Normally pregnant women have refractoriness to 
vasopressor substances viz., angiotensin II, norepinephrine, and vasopressin. In 
preeclampsia this refractoriness is lost and there is increased vascular reactivity1. 
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The vasoactive substances which bring about these changes are 
• Prostaglandins: A number of prostaglandins are central to the pathophysiology of 
the preeclampsia syndrome. Specifically, the blunted pressor response seen in 
normal pregnancy is at least partially due to decreased vascular responsiveness 
mediated by vascular endothelial prostaglandin synthesis. When compared with 
normal pregnancy, endothelial prostacyclin (pgi2) production is decreased in 
preeclampsia.  
• Endothelins: These are potent vasoconstrictors with 21 amino acid peptides and 
endothelin 1 is the primary isoform produced by human endothelium. Plasma ET1 
is the primary isoform produced by human endothelium. Plasma ET1 is increased 
in normotensive pregnant women, but women with preeclampsia have even higher 
levels. Interestingly treatment of preeclamptic women with magnesium sulphate 
lowers ET1 concentration1, 17. 
Angiogenic factors: Placental vasculogenesis is evident by 21days after conception. 
Angiogenic imbalance is used to describe excessive amounts of antiangiogenic factors 
that are hypothesised to be stimulated by worsening hypoxia at the uteroplacental 
interface. 
Trophoblastic tissue of women destined to develop preeclampsia overproduces at least 
two angiogenic peptides that enter the maternal circulation. 
• Soluble fms like tyrosine kinase 1(sFlt-1): it is a variant of the sflt 1 receptor for 
placental growth factor and vascular endothelial growth factor. Increased maternal 
sflt 1 levels inactivate and decrease circulating free plgf and vegf concentrations 
leading to endothelial dysfunction. Sflt 1 level begins to increase in maternal 
serum months before preeclampsia is evident1, 16. 
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• Soluble endoglin (seng): it is a placental derived 65 Kda molecule that blocks 
endoglin, also called cd105, which is a co receptor for the tgf b family. This 
soluble form of endoglin inhibits various tgf b isotopes from binding to 
endothelial receptors and result in decreased endothelial nitric oxide dependent 
vasodilation1, 16. 
The cause of placental overproduction of antiangiogenic proteins remains an enigma. 
The soluble forms are not increased in the fetal circulation or amniotic fluid, and their 
levels in maternal blood dissipate after delivery. Widmer and associate concluded that 
retrospective studies shows that third trimester elevation of sflt 1 levels and decreased 
plgf concentration correlate with preeclampsia development after 25 weeks as shown 
in Figure 3. 
Role of nitric oxide: This is a potent vasodilator which is synthesised from L arginine 
by endothelial cells of blood vessels of the mother and also fetus. It maintains the 
normal low pressure vasodilated state which is characteristic of fetoplacental 
perfusion. 
The effect of nitric oxide production in preeclampsia is unclear. It appears that the 
syndrome is associated with decreased endothelial nitric oxide synthetase expression 
thus increasing nitric oxide inactivation. These responses may be race related, with 
African American women producing more nitric oxide1, 17. 
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FIGURE-345.Angiogenic factors in pathogenesis of preeclampsia. 
 
 
 
 
 
 
 
 
 
In summary the cause of preeclampsia remains obscure, although more and more 
evidence is accruing to support the hypothesis that placenta plays a crucial role. Some 
describe aetiology as a two-step process. The first as asymptomatic stage (placental) 
involves abnormal placentation which is then followed by placental elaboration of 
soluble factors that enters the maternal circulation and causes widespread endothelial 
dysfunction as shown in Figure 4. 
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FIGURE- 415. Pathogenesis of preeclampsia 
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SCREENING FOR HYPERTENSIVE DISORDERS OF PREGNANCY  
Preeclampsia and intrauterine growth restriction remain important causes of maternal 
and perinatal morbidity and mortality30, 31, 32. Maternal complications of preeclampsia 
include coagulopathy, renal and liver failure and stroke32. Adults who were affected 
by intrauterine growth restriction in utero are at increased risk for cardiovascular 
disease, hypertension and type 2 diabetes33, 34.The substantial loss of life as well as 
serious long term sequel of preeclampsia could be largely eliminated if we could 
accurately predict, prevent and better manage preeclampsia. It is evident at the present 
time that there is no clinically useful test to accurately predict preeclampsia. 
Delineation of a reliable and safe screening test for preeclampsia has been an 
investigators dream for many decades and an extensive systematic review of most of 
these tests was published in 2004.  87 out of 7,191 potentially relevant articles that 
described a variety of biophysical and biochemical tests assessing their usefulness in 
predicting preeclampsia were analysed. The conclusion was that there were no 
clinically useful screening tests to predict the development of preeclampsia18.  
Attempts have been made to identify early markers of faulty placentation, impaired 
placental perfusion, endothelial cell activation and dysfunction, and activation of 
coagulation.  
The list of predictive factors evaluated during the past three decades is legion. 
Although most have been evaluated in the first half of pregnancy, some have been 
tested as predictors of severity in the third trimester. Others have been used to forecast 
recurrent preeclampsia. Table 3 shows the list of markers studied since 1980s for the 
prediction of development of preeclampsia20. 
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TABLE-3.List of markers for prediction of preeclampsia. 
Placental perfusion and vascular resistance dysfunction related tests: 
Mean blood pressure in second trimester 
Roll over test 
Isometric exercise test 
Platelet angiotensin II binding 
24 hr ambulatory blood pressure monitoring 
Doppler ultrasound 
Fetoplacental unit endocrinology dysfunction- related tests: 
HCG 
Alpha fetoprotein 
Estriol 
Inhibin A 
Pregnancy associated plasma protein A 
activinA 
corticotrophin release hormone 
Renal dysfunction related tests: 
Serum uric acid 
Microalbuminuria 
Urinary calcium excretion 
Urinary kallikrein 
Microtransferrinuria 
Endothelial and oxidant stress dysfunction related tests/ inflammatory markers: 
Platelet count 
Fibronectin 
Platelet activation and endothelial cell adhesion molecules 
Endothelin 
Prostacyclins 
Thromboxane 
Homocysteine 
Serum lipids 
Insulin resistance 
Antiphospholipid antibodies 
Plasminogen activator inhibitor 
Placental growth factor 
Leptin 
Total proteins 
Antithrombin III 
Haptoglobin 
Atrial natriuretic peptide 
Beta2 microglobulin 
CRP 
Genetic markers 
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1) Vascular Resistance Testing and Placental Perfusion 
Most of these are cumbersome, time consuming, and overall inaccurate. 
• Provocative Pressor Tests: Three tests have been extensively evaluated to assess 
the blood pressure rise in response to a stimulus. The roll-over test measures the 
hypertensive response in women at 28 to 32 weeks who are resting in the left 
lateral decubitus position and then roll over to the supine position. Increased blood 
pressure signifies a positive test. The isometric exercise test employs the same 
principle by squeezing a handball. The angiotensin II infusion testis performed by 
giving incrementally increasing doses intravenously, and the hypertensive 
response is quantified. In their updated metaanalysis, Conde-Agudelo and 
associates (2014) found sensitivities of all three tests to range from 55 to 70 
percent, and specificities approximated 85 percent. 
• Uterine Artery Doppler Velocimetry: Faulty trophoblastic invasion of the spiral 
arteries results in diminished placental perfusion and upstream increased uterine 
artery resistance. Increased uterine artery velocimetry determined by Doppler 
ultrasound in the first two trimesters should provide indirect evidence of this 
process and thus serve as a predictive test for preeclampsia (Gebb, 2009a, 
b;Groom, 2009).  Increased flow resistance results in an abnormal waveform 
represented by an exaggerated diastolic notch. These have value for fetal-growth 
restriction but not preeclampsia (American College of Obstetricians and 
Gynecologists, 2013a). Several flow velocity waveforms, alone or in combination 
have been investigated for preeclampsia prediction. In some of these, predictive 
values for early-onset preeclampsia were promising (Herraiz, 2012).At this time, 
however, none is suitable for clinical use (Conde-Agudelo, 2014; Kleinrouweler, 
2012; Myatt, 2012a). 
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• Pulse Wave Analysis: Like the uterine artery, finger arterial pulse “stiffness” is 
an indicator of cardiovascular risk. Investigators have preliminarily evaluated its 
usefulness in preeclampsia prediction (Vollebregt, 2009). 
2)Fetal-Placental Unit Endocrine Function 
Several serum analytes have been proposed to help predict preeclampsia. Many of 
these gained widespread use in the 1980s to identify fetal malformations and were 
also found to be associated with other pregnancy abnormalities such as neural-tube 
defects and aneuploidy. Although touted for hypertension prediction, in general, none 
of these tests has been shown to be clinically beneficial for that purpose. 
3) Tests of Renal Function 
• Serum Uric Acid: One of the earliest laboratory manifestations of preeclampsia 
is hyperuricemia (Powers, 2006). It likely results from reduced uric acid clearance 
from diminished glomerular filtration, increased tubular reabsorption and 
decreased secretion (Lindheimer, 2008a). It is used by some to define 
preeclampsia but Cnossen and coworkers (2006) reported that its sensitivity 
ranged from 0 to 55 percent, and specificity was77 to 95 percent. 
• Microalbuminuria. As a predictive test for preeclampsia, microalbuminuria has 
sensitivities ranging from 7 to 90 percent and specificities between 29 and 97 
percent (Conde-Agudelo,2014). Poon and colleagues (2008) likewise found 
unacceptable sensitivity and specificity for urine albumin:creatinine ratios. 
4) Endothelial Dysfunction and Oxidant Stress 
Endothelial activation and inflammation are major participants in the pathophysiology 
of the preeclampsia syndrome. As a result, compounds such as those listed in Table-3 
26 
 
are found in circulating blood of affected women, and some have been assessed for 
their predictive value. 
• Fibronectins: These high-molecular-weight glycoproteins are released from 
endothelial cells and extracellular matrix following endothelial injury (Chavarria, 
2002). More than 30 years ago, plasma concentrations were reported to be 
elevated in women with preeclampsia (Stubbs, 1984). Following their systematic 
review, however, Leeflang and associates (2007) concluded that neither cellular 
nor total fibronectin levels were clinically useful to predict preeclampsia. 
• Coagulation Activation: Thrombocytopenia and platelet dysfunction are integral 
features of preeclampsia. Platelet activation causes increased destruction and 
decreased concentrations, and mean platelet volume rises because of platelet 
immaturity (Kenny, 2014). Although markers of coagulation activation are 
increased, the substantive overlap with levels in normotensive pregnant women 
stultifies their predictive value. 
• Oxidative Stress: Increased levels of lipid peroxides coupled with decreased 
antioxidant activity have raised the possibility that markers of oxidative stress 
might predict preeclampsia. For example, malondialdehyde is a marker of lipid 
peroxidation. Other markers are various prooxidants or their potentiators. These 
include iron, transferrin, ferritin, blood lipids, including triglycerides, free fatty 
acids and lipoproteins and antioxidants such as ascorbic acid and vitamin E 
(Bainbridge,2005; Conde-Agudelo, 2014; Mackay, 2012; Powers, 2000).These 
have not been found to be predictive. 
Hyperhomocysteinemia causes oxidative stress and endothelial cell dysfunction and is 
characteristic of preeclampsia. Although women with elevated serum homocysteine 
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levels at midpregnancy had a three to fourfold risk of preeclampsia, these tests have 
not been shown to be clinically useful predictors (D’Anna, 2004; Mignini, 2005; 
Zeeman, 2003). 
5)Circulating Angiogenic Factors.  
Host of recent studies throw light on the role of angiogenic proteins in the 
pathogenesis. There is an imbalance of pro and antiangiogenic factors. Two 
antiangiogenic factors implicated are soluble fms like tyrosine kinase1receptor/ sflt 1 
and  solubleendoglin /seng 1 whose levels are elevated in women with preeclampsia. 
Pro angiogenic proteins decreased in preeclampsia are vascular endothelial growth 
factor/vegf and placental growth factor/ plgf. Vegf- endothelial specific mitogen 
promotes angiogenesis mediated by 2 high affinity receptor tyrosine kinases vegfr-1 
(flt 1) and vegfr- 2 (kinase insert domain region) selectively expressed on vascular 
endothelial cell surface. Vegfr 1 has 2 isoforms – a transmembranous isoform and a 
soluble isoform (svegfr 1 or sflt 1). Sflt 1 can antagonise biological activity of vegf 
and also of plgf.  sflt 1 is elevated during clinical preeclampsia. This is associated 
with fall in free plgf and vegf. 
Soluble endoglin (antiangiogenic) which is tgf b1 co-receptor impairs tgfb1 binding to 
cell surface receptors and decrease endothelial nitric oxide signalling. Recently seng 
is demonstrated in high concentration in sera of pregnant women, increased in 
preeclampsia. Urine screening with plgf assay followed by blood confirmation with 
sflt 1/plgf can be done. Recently isoforms of sflt 1-14 produced by the placenta is 
found.Vegf165b is a variant of vegf pre mRNA is upregulated in maternal circulation 
in normal pregnancy but this increase is delayed or diminished in women who 
develop preeclampsia. Sensitivities for all cases of preeclampsia ranged from 30 to 50 
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percent and specificity was about 90 percent. Their predictive accuracy was higher for 
early-onset preeclampsia. These preliminary results suggest a clinical role for 
preeclampsia prediction.  
6) Cell-Free Fetal DNA 
 Cell-free fetal DNA can be detected in maternal plasma. It has been reported that 
fetal maternal cell trafficking is increased in pregnancies complicated by preeclampsia 
(Holzgreve, 1998). It is hypothesized that cell free DNA is released by accelerated 
apoptosis of cytotrophoblasts (DiFederico, 1999). From their review, Conde-
Agudeloand associates (2014) concluded that cell-free fetal DNA quantification is not 
yet useful for prediction purposes. 
7) Proteomic, Metabolomic, and TranscriptomicMarkers 
Methods to study serum and urinary proteins and cellular metabolites have opened a 
new vista for preeclampsia prediction. 
• Placental protein 13/pp13: It is the member of galectin family expressed 
predominantly by the placenta (syncytiotrophoblast) thought to be involved in 
implantation and maternal artery remodelling. Maternal serum 1st trimester pp 
13 helps in predicting preeclampsia mainly the early onset preeclampsia. 
Various studies show that maternal serum pp 13 concentration are 
significantly reduced during the first trimester among women who 
subsequently develop preeclampsia – early onset. 
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ROLE OF DOPPLER ULTRASONOGRAPHY IN PREGNANCY INDUCED 
HYPERTENSION 
The condition of pregnancy induced hypertension is often predictable with twin 
pregnancy, diabetes, in elderly women and certain autoimmune diseases and renal 
diseases like nephritic syndrome. In such conditions, vigilant obstetrician can always 
suspect and diagnose it early and treat accordingly. However, in some women this 
condition sets in a subtle way and gradually such women develop severe degree of 
preeclampsia leading to dreadful complications. Hence in routine antenatal care, if 
any predictive test can be applied as a screening test for all women, then this dreadful 
multisystemic condition can be treated in time1. 
Introduction to Doppler Ultrasonography 
Doppler ultrasonography makes use of the concepts: 
 Doppler Effect 
 Doppler Shift 
Doppler Effect: When a sound wave hits a moving object, the frequency of the 
reflected wave depends on the speed and direction of the moving object. When a 
source of a wave and the observer move closer the frequency of the reflected wave 
increases and when they move apart, the frequency decreases. 
Doppler Shift: It is the difference in the frequency of the emitted and the reflected 
wave. It is also called frequency shift. 
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Doppler equation is given by and is shown in Figure 5. 
 =
2. 	


 
fo: incident ultrasound beam frequency 
fd: frequency shift 
A:angle between the incident ultrasound beam and axis of blood flow 
C:speed of sound in medium 
V:velocity of blood flow 
FIGURE- 59.The Doppler shift and the derivation of equation. 
The velocity of flow in a particular vascular bed is inversely proportional to the 
downstream impedance of flow. 
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The frequency shift depends on  
• The downstream impedance to flow and 
• The cosine of angle the ultrasound beam makes with blood vessel. If 
A=00cosA=1,the maximum velocity and if A=900, cosA=0,there is no 
Doppler shift as shown in figure-5. 
Ideally one should measure velocity with as small an angle as possible. Usually 30-
600 angle is used. 
Doppler indices 
 Figure-6 shows the waveform obtained from the blood vessel and it has a first peak 
corresponding to systole(S) and a second peak corresponding to diastole(D). M is the 
mean of both the systolic and diastolic velocities. 
FIGURE 6- .Doppler waveform. 
 
 
 
 
 
 
 
 
 
The various Doppler indices used in clinical practice are  
• Pulsatility index= peak systolic velocity – end diastolic velocity/mean velocity (S-
D/M) 
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• Resistivity index= peak systolic velocity – end diastolic velocity/systolic velocity 
(S-D/S) 
• Peak systolic velocity/ end diastolic velocity (S/D) ratio 
• End diastolic velocity/ mean velocity (D/M) ratio 
S/D ratio is simple and describes the rate at which flow velocities fall away during 
diastole. This closely corresponds to the peripheral resistance to blood flow. 
Increasing peripheral resistance causes an increase in pulsatility and PI. As peripheral 
resistance is increased, systolic peak decreases and thus decreased PI. When end 
diastolic frequencies disappear, D is 0 and S/D is infinity and RI is1. 
Doppler modes 
• Continuous wave Doppler: The transducer assembly contains two elements, one 
for continuous transmitting and other for receiving. Advantages are that it can be 
used for vascular diagnosis. E.g. Umbilical artery Doppler velocimetry, external 
fetal heart rate monitoring. It is inexpensive and has low acoustic energy output. 
Disadvantage is that it cannot discriminate between different locations from which 
the signal is originating. 
• Pulsed wave Doppler: Here the same crystal functions both as transmitter and 
receiving transducer. The advantage is that it gives velocity information of 
specific target vessel and the disadvantage is that it fails if the operator is unable 
to identify the correct location and has sampling limitation and range velocity 
limitations. It is useful in uterine artery Doppler and assessing fetal circulation. 
• Colour flow Doppler: It is an extension of pulsed Doppler where colour signal is 
assigned. It is conventional to use red to designate flow towards the probe and 
blue away from it. Advantage is that it can detect blood flow velocity in the same 
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plane and also direction and small blood vessels can be visualised. Disadvantage 
is that, there is absence of spectral display and absence of colour does not 
necessarily indicate absence of flow. 
• Power Doppler: It is a recent development and quantifies and displays flow 
information as an amplitude of scatter of the ultrasound beam rather than as a 
frequency shift. The advantage is that the blood flow velocity is independent of 
the angle of insonation and helpful in high blood flow velocity assessment. 
Other modes of Doppler are two dimensional Doppler and high definition Doppler. 
Modes of Doppler ultrasound mapping 
• Colour flow mapping: Map of vessels are obtained which is superimposed on 
the grey scale image 
• Doppler spectrum: Graph showing flow characteristics as a waveform. These 
are then quantified as velocities, ratios and indices9. 
Uterine artery Doppler 
Rationale for uteroplacental waveform analysis 
Uteroplacental waveforms are acquired from the uterine artery by means of colour, 
pulsed Doppler ultrasound. As it was not always possible to determine whether these 
waveforms arose from the uterine artery or the arcuate artery by using pulsed wave 
Doppler alone, they are still commonly referred to as uteroplacental waveforms. With 
the use of color Doppler, the uterine artery can be reliably identified so that pulsed 
wave doppler information can be acquired. Failure or poor trophoblastic invasion is 
characteristic of pre-eclamptic and growth-restricted pregnancies. Assessment of 
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uterine artery blood flow is an established screening test for these pregnancy 
problems7. 
Finding the uterine artery waveform 
Ideally, the equipment should be designed specifically for obstetric purposes as 
cardiovascular equipment has high power output levels. Ideally 4 MHz probe has to 
be selected and the vessel wall filter (also known as the thump filter) has to be set to 
50 Hz, the frequency range to 4 kHz and the sweep speed to 5 m /s. It has to be 
ensured that the balance control is exactly at its midposition and that the gain control 
is set at about 50% of maximum.  
 
Figure:7 Showing different probes and there specifications. 
 
Use of color flow imaging to identify the bifurcation of the common iliac artery 
in longitudinal  section. 
The uterine artery originates from the internal iliac artery and meets the uterus just 
above the cervix. The main uterine artery branches into the arcuate arteries, which 
arch anteriorly and posteriorly and extend inward for about one third of the thickness 
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of the myometrium. They are tortuous and vary in thickness and in the area they 
supply. The arcuate artery network anastomoses near the midline. The radial arteries 
arise from this network, are directed towards the uterine cavity, and become spiral 
arteries when they enter the endometrium5. 
 The probe is moved medially and angled slightly towards the symphysis pubis to 
reveal the uterine artery just medial to the bifurcation, as it ascends toward the uterus. 
It is conventional to place the uterine artery sample gate of the pulsed wave Doppler 
at the point of maximal colour brightness close to the bifurcation as shown in Figure 
7. When the waveform is seen, the frequency range is altered on the equipment until 
the waveform fills about two-thirds of the height of the screen. The waveform itself 
will contain a range of frequencies, represented by a range of differing colours within 
it as shown in Figure 8. If the waveform obtained appears very bright, contains few 
colours and the background is noisy, then the Doppler gain is reduced until the 
optimal balance is obtained7. 
FIGURE-8.  Localising uterine artery. 
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FIGURE:9- .Obtaining uterine artery waveform.(normal waveform) 
 
 
 
 
FIGURE: 10 Non pregnant uterine artery wave form 
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FIGURE: 11 First trimester uterine artery wave form. 
 
 
 
FIGURE: 12 Second trimester uterine artery wave form 
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FIGURE: 13 Abnormal wave form with high RI 
 
 
FIGURE: 14 Notching in second trimester. 
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Taking measurements 
After obtaining an optimal waveform, the image has to be freezed when the automatic 
calculations are displayed. The three waveforms that the machine has chosen to 
ensure that they are free from substantial noise and that the machine has correctly 
chosen the maximum systolic point and the lowest frequency in end-diastole are 
examined. If the machine does not have a maximum frequency follower then the 
image is freezed and Doppler indices are measured manually. Various measurements 
of the uterine artery waveform can be calculated. The most commonly used is the 
resistance index (RI). The systolic/diastolic (S/D) ratio and pulsatility index (PI) can 
also be used   as shown in figure 9 and 10. 
FIGURE-15. Doppler indices commonly used. 
 
 
 
 
 
 
FIGURE- 16. Uterine artery Doppler study with reporting.(right side) 
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Reporting of uteroplacental waveforms 
Loss of end-diastolic frequencies is extremely rare in the uteroplacental circulation so 
a simple index of impedance to flow, such as the RI or PI, is sufficient. A subjective 
assessment of the flow velocity waveform is also usually performed to note the 
presence or absence of notches. The waveforms from both sides of the uterus are 
recorded and reported as follows: 
High resistance pattern: 
 Persistent diastolic notch-bilateral notches. 
 Persistent high impedance- RI>0.6 or more than 95th percentile for the 
gestational age or PI > 1.6 or more than 95th percentile for the gestational age. 
 Significant difference between the flow of right and left uterine arteries. 
 S/D > 2.6.  
Impaired uterine artery Doppler is seen in 
• Fetal growth restriction  
• Preeclampsia 
• Preterm delivery 
• Non reassuring fetal status in labour. 
Low resistance pattern: All other situations as shown in the Figure12 which is a 
normal Doppler waveform.  
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FIGURE 17 .Abnormal color Doppler waveform of the uterine artery at 24 
weeks with the presence of a‘notch’ at the end of systole and reduced                       
end-diastolic flow. 
 
 
 
 
 
 
 
 
 
FIGURE18 -.Normal color Doppler waveform of the uterine artery at 24 weeks. 
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Problems 
If the signal is not visualized the machine settings are checked and restarted. The 
vessel wall filter, frequency range, sweep speed and gain controls should be 
rechecked. 
When there is difficulty in distinguishing waveforms from the Internal iliac artery 
from pathological Uteroplacental waveforms, pathologic uteroplacental waveforms 
are identified by  a biphasic deceleration slope in systole, whereas those from the 
internal iliac artery have a smooth, steep slope. 
FIRST TRIMESTERSCREENING 
 
According to Pilaliset al (2007 : 532), 1st trimester abnormal uterine artery 
Doppler flow patterns are likely to identify the cases of pre-eclampsia 
associated with severe growth restriction and have a greater sensitivity in 
identifying early onset of severe disease. A 1st trimester uterine artery Doppler 
assessment is thus useful in identifying a subgroup of the population at n 
considerable risk for early, severe pre-eclampsia or growth 
restriction(Pilalisetal2007; 532) 
In a study done by Pilalis et al the results suggest that uterine artery Doppler 
examinations are helpful in predicting pre-eclampsia from as early as 
the1sttrimester (Pilalis et al., 2007 :139). 
 
Melchiorre and co workers (2000 : 135) found that 1st trimester uterine artery 
Doppler indices and prevalence of bilateral notching in normal pregnancies were 
considerably different from those in women destined to develop preterm 
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pre-eclampsia but not term pre-eclampsia. The results of a study done by 
Melchiorre and coworkers (2009:528 )indicated a significant relationship between 
1sttrimester uterine artery Doppler indices and the consequent development to small 
for gestational  age fetuses. 
SECOND TRIMESTERSCREENING 
Second trimester uterine artery Doppler screening has proven to be a sensitive 
and accurate method for predicting preeclampsia and fetal growth restriction 
especially the severe forms and early onset of the disease(Pilalis2007:533) 
Doppler screening in the second trimester is more sensitive than in the 
1sttrimester, in identifying the more severe and therefore clinically most relevant 
cases of pre-eclampsia and FGR. 
IDEAL TIME FORSCREENING 
Screening for pre-eclampsia by uterine artery Doppler assessments is possible 
from at least 11 weeks of gestation. Trophoblastic invasion is maximal in the 
1sttrimesterand pre-eclampsia develops from a relative failure of this event, 
validates the evaluation of uterine artery Doppler assessment in the 
1sttrimester(Melchiorrie2008: 133), however screening too early leads to false 
positive rates and lower positive predictive values as what appears to be 
abnormal uterine artery Doppler waveforms in early second trimester may fully 
develop and normalize by late second trimester(Swanepoel2004 :6). 
Screening in these second trimester leads to improvement in the false 
positive rates and positive predictive values(Swanepoel2004:6). 
Cnossen and colleagues (2008: 703), echo Swanepoel's view that Doppler 
testing for both preeclampsia and FGR is less accurate in the 1sttrimester than in 
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the 2ndtrimester, while Papageorghiou (2008 : 308) argued that in the 1st 
trimester the sensitivity for predicting severe or early onset disease is much 
higher than is for mild or late onset disease. Melchiorrie (2005 : 134) is of the 
opinion that 1standearlysecond trimester tests are only likely to be able to predict 
the  development of preterm pre-eclampsia cases that have defective spiral 
artery changes. 
Numerous studies found the potential advantage of earlier screening is that 
prophylactic intervention, such as maternal ingestion of low dose aspirin may be 
more effective in the prevention of the subsequent development of pre-
eclampsia and FGR  (Martinetal.,2001:586), 
Aspirin therapy may be of specific benefit if started in the first trimester in 
women at high risk of developing the disease on the basis of history and 
abnormal first trimester uterine artery Doppler waveforms (Papageorghiou 2000 
: 369). In a study by Yu and coworkers, (2003 :238) there is particular evidence 
that the administration of low dose aspirin to women with abnormal flow in 
theuterinearteriesatthisearlystagemayprovideeffectiveprophylaxisagainstpre-
eclampsia. 
A reason for a move towards first trimester screening is that prevention of 
pre-eclampsia by starting pharmacological intervention in the second trimester has 
by and large failed  (Papageorghiou  2008  :369). 
Screening of high-risk populations 
Women at increased and/or high-risk for preeclampsia and intrauterine growth 
restriction are usually identified from the maternal history at pregnancy booking. The 
prevalence of complications in this group of pregnancies is much higher than in the 
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normal population. Uterine artery Doppler screening is a validated screening tool for 
this group.  
Screening of low-risk pregnancies 
Although several studies have used uterine artery Doppler as a screening tool for 
preeclampsia and fetal growth restriction in unselected populations, debate continues 
as to its value. Varying sensitivities are obtained depending on the type of Doppler 
used, the sampling site, the definition of abnormal uterine artery resistance, gestation 
of assessment and different end-points. Currently, the following statements are 
supported by at least one published study for two-stage (20- and 24-week) screening, 
using color pulsed wave doppler of the uterine arteries: 
● The presence of a low resistance pattern is associated with a very low chance of 
pregnancy complications: 
Less than 1% chance of developing proteinuric hypertension. 
Less than 1% chance of a coexisting small for- gestational-age fetus. 
● A high resistance pattern is associated with a higher rate of pregnancy 
complications: 
70% chance of developing proteinuric hypertension 
30% chance of a coexisting small-for-gestational- age fetus.7 
Uterine artery Doppler studies in normal pregnancy 
Schulman and colleagues determined that in the non pregnant state there is a rapid rise 
and fall in uterine artery flow velocity during systole and a notch in the descending 
waveform in early diastole. During pregnancy, they noted a significant increase in 
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uterine artery compliance between 8 and 16 weeks, which continued to a lesser extent 
until 26 weeks gestation. This physiological change in compliance resulted in the loss 
of the diastolic notch between 20 and 26 weeks gestation. This finding was 
corroborated by Jurkovic and Juaniaux who found similar changes in the resistance 
index(RI) and pulsatility index(PI) of the uterine artery Doppler signal. They 
determined that the RI decreased from 0.8 to 0.63 between 8 and 17 weeks, and that 
the PI decreased from 2.0 to 1.3 between 8 and 18 weeks gestation.43 
Criteria for an abnormal test 
The majority of research has centred on an elevation in the PI or the persistence of a 
uterine artery diastolic notch to detect the presence of increased uteroplacental 
vascular resistance. 
A recent metaanalysis concluded that a PI with notching had the best predictive value 
for pregnancy outcomes (Cnossen’s). It appears that as the impedance to flow 
increases in the placenta there is momentary closure of the uterine artery in the late 
systole or early diastole, or an increase in the downstream resistance as the relatively 
inflexible distal artery recoils from distension caused by the systolic pulse. This is 
manifested as an early diastolic   notch in the Doppler waveform. Most studies use 
subjective criteria for the definition of a diastolic notch, but a drop of atleast 50 cm/s 
from the maximum diastolic velocity is a reasonable criteria after 20 weeks.43 
There are no current standards for gestational age at testing or criteria for an abnormal 
uterine artery Doppler study. Once adequately trained in the technique, a reasonable 
approach would be to use an ultrasound machine with the capability to perform 
continuous wave and or pulsed wave Doppler studies of the uterine, arcuate and the 
subplacental arteries. 
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 PI has been commonly reported but using levels above the 95th percentile or PI>1.6 
appears to be appropriate. Recent reports show some utility in assessment of uterine 
artery flow in the first trimester. However the second trimester has yielded more 
consistent results. Performance at 18-20 weeks gestation is a reasonable approach. 
There is some evidence that repeating tests at 24- 26 weeks may add further 
benefits.43 
STUDIES 
Cnossen JS, Morris RK et al made  a systematic review and bivariable meta-analysis 
in which they identified relevant studies through various databases of April 2006 and 
found that  uterine artery Doppler ultrasonography provided a more accurate 
prediction when performed in the second trimester than in the first-trimester and an 
increased pulsatility index with notching was the best predictor of preeclampsia 
(positive likelihood ratio 21.0 among high-risk patients and 7.5 among low-risk 
patients). It was also the best predictor of overall (positive likelihood ratio 9.1) and 
severe (positive likelihood ratio 14.6) intrauterine growth restriction among low-risk 
patients. 
Bhattacharyya Sanjoy Kumar, KunduSarmila and Kabiraj Sankar Prasad made  a 
prospective study of 179 pregnant women  of gestational age less than 16 weeks from 
August 1, 2007 to July 31, 2008 to predict the occurrence of preeclampsia using 
uterine artery Doppler velocimetry as a screening test at 24 to 26 weeks of gestation 
to note the abnormalities i.e., notching, resistivity index>0.6. They divided them into 
high and low risk group and followed up to look for the development of preeclampsia. 
It was found that sensitivity and specificity of abnormal uterine artery Doppler study 
for prediction of preeclampsia were 73.33 and 86.48% in high risk and 57.14 and 
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95.83% in low risk group. Relative risk with 95% confidence interval was 
5.427(2.272-12.958) in high risk and 13.65(5.669-32.865) in low risk women and 
concluded that Doppler velocimetry of uterine artery at 24 weeks can be a reliable 
screening test for prediction of preeclampsia in both high risk and low risk women19. 
Steel SA, Pearce JM et al in January 2001 made a study on early Doppler ultrasound 
screening in prediction of hypertensive disorders of pregnancy in which they screened 
1198 nulliparous women in early pregnancy by Doppler ultrasound waveforms 
(median 18 weeks). Among 1014 available for analysis, 118(12%) had persistently 
abnormal waveforms on repeat ultrasound scans at 24 weeks. Hypertension was 
significantly more frequent among those women than among women with normal 
Doppler waveforms [29/118 (25%) vs. 45/896 (5%)]. Hypertension in women with 
abnormal waveforms was more likely to be severe; 12 (10%) had proteinuria and 15 
(13%) intrauterine growth retardation compared with 7 (0.8%) and 0, respectively, of 
those with normal waveforms. The sensitivity was high for hypertension associated 
with either proteinuria (63%) or intrauterine growth retardation (100%). 
Caforio L, Testa AC et al studied uterine artery Doppler velocimetry performed at 18-
20 and 22-24 weeks of gestation in predicting preeclampsia and adverse pregnancy 
outcome in high and low risk patients. 865 pregnant women were evaluated: 335 and 
530 pregnant women represented the high and low-risk groups, respectively. At 18-20 
weeks of gestation the sensitivity for the prediction of preeclampsia was 100 and 94% 
in low and high-risk groups, respectively. At 22-24 weeks of gestation the sensitivity 
for the prediction of preeclampsia was 100 and 97% in low and high-risk groups, 
respectively. They concluded that Doppler evaluation of the uterine artery at 18-20 
and 22-24 weeks of gestation represents a useful predictive test in high-risk pregnancy 
and can also be used in prenatal surveillance of a low-risk population. 
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Schwarze A, Nelles I, et al in 2000 made a study to assess the role of uterine artery 
colour Doppler waveform analysis in the prediction of adverse pregnancy outcome 
such as preeclampsia, intrauterine growth retardation, placental abruption or a 
combination of outcome parameters. They found that in low risk pregnancies, the 
sensitivity of uterine artery notching for prediction of preeclampsia was 88 % and 
concluded that the predictive value of uterine artery Doppler for adverse pregnancy 
outcome in a low-risk population is of limited diagnostic value. Performing uterine 
artery Doppler studies at 23-26 weeks' gestation instead of 19-22 weeks' gestation 
increases the predictive value for adverse pregnancy outcomes. 
Coleman et al made a study on mid trimester uterine artery Doppler screening as a 
predictor of adverse pregnancy outcome in high risk women. In their study, the 
sensitivity and specificity of RI>0.58 for preeclampsia was found to be 91 and 42 % 
respectively. Among women with RI ≥0.7, 58 % developed preeclampsia. 
Ratanasiri T during 2004-2005 made a prospective study to assess the performance of 
diastolic notch of uterine arteries as a predictor for preeclampsia among 378 pregnant 
women between 18 to 22 weeks of gestation using Doppler studies. Diastolic notch 
was found in one or both uterine arteries in 51 subjects, yielding 78.6% sensitivity, 
89.0% specificity, 21.6% positive predictive value, 99.1% negative predictive value, 
88.6% accuracy, with likelihood ratio of positive and negative test result of 7.2 and 
0.2 respectively in the prediction of preeclampsia. They concluded that although 
having high sensitivity and specificity, diastolic notch of uterine artery found in the 
second trimester provides too low predictive value to be used as a routine screening 
for preeclampsia. 
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Chien PF, Arnott N et al in 1999 made a quantitative systematic review of 
observational diagnostic studies using online searching of the medline database and 
found that in the low risk population a positive test result predicted preeclampsia with 
a pooled likelihood ratio of 6 x 4 (95% CI 5 x 7-7 x 1), while a negative test result had 
a pooled likelihood ratio of 0 x 7 (95% CI 0 x 6-0 x 8) and concluded that uterine 
artery Doppler flow velocity has limited diagnostic accuracy in predicting 
preeclampsia, intrauterine growth retardation and perinatal death. 
ArisAntsaklis, George Daskalakis in 2010 in their study concluded that uterine artery 
Doppler screening meets all the requirements for a worthwhile screening program in 
prediction of preeclampsia. The sensitivity for predicting severe preeclampsia was 
between 80 and 90% for a false positive rate of 5 to 7% and that the detection rate 
could be better if they would have set a higher screen positive rate. Uterine artery 
screening at 20-24 weeks gestation was found to be superior to first trimester 
screening. 
   C K H Yu, O Khouri et al in 2008 made a multicentre prospective Doppler study of 
the uterine artery at 22-24 weeks of gestation in unselected women with singleton 
pregnancies and found that in 30,639 pregnancies, the median uterine artery 
pulsatality index was 1 and 95th percentile was1.58. 614(2%) of cases developed 
preeclampsia and the mean uterine artery PI was above 95th centile in 77.2% of 
women who developed preeclampsia requiring delivery before 34 weeks, in 35.9% of 
those delivering at 34-37 weeks and in 21.9% of those delivering after 37 weeks. The 
respective percentages were 82.3%, 46.9% and 28.8% for those with preeclampsia 
and small for gestational age infants and 43.8%, 21.2% and 8.4% for those with small 
for gestational age but without preeclampsia. 
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Progrojpaw D et al in 2008 screened 330 singleton high risk pregnancies with uterine 
artery Doppler between 20 and 24 weeks. Pulsatility index of > 1.58 or the presence 
of diastolic notch were defined abnormal and found that 27 (8.18%) women 
developed preeclampsia. 16 (4.84%) women has SGA babies. The sensitivity of PI > 
1.58 and diastolic notch for preeclampsia, SGA were 59.25% and 56.25% 
respectively. The specificity of PI>1.58 and diastolic notch for these outcomes were 
66.67% and 65.60% respectively  and concluded that mid trimester  uterine artery 
Doppler waveform analysis cannot be used as screening  method  in women at higher  
risk for the development of preeclampsia and SGA babies. 
Onwudiwe N, Yu CK  et al in 2008 studied  3529 singleton pregnancies at 22-24 
weeks with combined  screening with  maternal demographic characteristics, uterine 
artery Doppler and mean arterial pressure. Multiple regression analysis was used to 
determine the significant predictors of pre-eclampsia, gestational hypertension and 
small for gestational age (SGA) among maternal characteristics, uterine artery 
pulsatility index and MAP. Among 3359  cases available,  preeclampsia  developed in 
101 ( 3%) in which 23 (0.7%) delivered before 34 weeks and 78 ( 2.3%) after 34 
weeks . 74 ( 2.2%) developed  gestational  hypertension, 366 (10.9%) delivered  SGA 
new-borns with no hypersensitive disorders and 2806 ( 83.8%) were  unaffected. 
Maternal characteristics, uterine artery-PI and  MAP provided significant independent  
contribution for a false positive rate of 10%, the estimated detection rates of early and 
late preeclampsia were 100% and 56.4% respectively  and concluded that the 
combination of test is an effective screening tool. 
Asnafi N, Hajina K in 2011 studied 70 high risk pregnant women with Doppler 
ultrasonography between 18-24 weeks for evaluation of uterine  artery notching and 
found that 27 women ( 39.20-%) had notching and birth weight range was 
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2,897.5±757.15 where as other 43 women with no notching had babies with birth 
weight 3,248.39±374.27. Preeclampsia, abruption and low birth weight babies were 
significantly higher in the group with notching but pre term delivery did not show any 
statistical difference between the two groups. 
Elisa Llurba , Elena Casseras et al in 2008 made a prospective study in women with 
singleton pregnancies at 19-22 weeks. They studied mean pulsatility index (MPI) of 
both uterine arteries in 6586 women.  Among 6035 women, preeclampsia developed 
in 75 (1.2%) and IUGR in 69 (1.1%) cases. Uterine artery mean PI was 0.99 and 90th  
centile was 1.4. For 10% false positive rate, uterine Doppler mPI identified 70.60% of 
pregnancies that subsequently developed early onset preeclampsia and 73.3% of 
pregnancies that developed early onset IUGR and had a lower detection rate for late 
onset forms of the disease (23.5% for preeclampsia and 30% for IUGR) 
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MATERIALS AND METHODS 
This was a prospective study involving 280 pregnant women. We excluded 30 cases 
because they had missing outcome data. In the remaining 250 pregnant women with 
gestational age 12 to 14 weeks and 20 to 26 weeks with correct LMP attending 
antenatal clinic at KGH Hospital, (tertiary health care centre) Triplicane & Institute of 
Obstetrics & Gynaecology, Egmore, Chennai, constituted the study population.  
After taking the informed written consent from the pregnant women willing to 
participate in the study, a preliminary data was collected to include 
Thorough history to know the patient demographics, gestational age and to know any 
high risk factors associated with the pregnancy. 
 BMI was calculated using the formula : weight (kg)/height (m2). 
Recording of blood pressure was done in sitting position after 10 minutes of rest the 
reading was repeated when above 140/90 mmHg after 4 hours.  
Preeclampsia is defined as a blood pressure of at least 140/90 mmHg measured on 
two occasions each 4 hours apart, accompanied by proteinuria of atleast 300 mg per 
24 hours, or at least 1+ on dipstick testing. 
Severe preeclampsia is defined as having one or more of the following criteria: 
• Blood pressure of at least 160/110 mm Hg measured on two occasions each 4 
hours apart. 
• Proteinuria of at least 5 g per 24 hr, or at least 3+ on dipstick testing, oliguria 
of less than 500ml per 24 hr. 
• Cerebral or visual disturbances 
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• Epigastric or right upper quadrant pain 
• Impaired liver function 
• Thrombocytopenia 
• Fetal growth restriction (defined as the condition in which the new-born has 
birth weight less than 10% for gestational age) 
Proteinuria was diagnosed on 2 midstream urine samples collected at least 4 hours 
apart showing albumin “+”or more using dipstick. Urinary tract infection was 
excluded by routine urine analysis. 
The protein portion of the dipstick reagent strip measures the protein based on the 
protein error of PH dye indicator, principle (method) using bromophenol blue. 
Development of colour range from yellow for negative through yellow green and 
green to green blue for a positive reaction50,51. 
Table -4.Showing sensitivity/ limit of detection of urinary protein. 
Test result Negative Traces(+/-) 1+ 2+ 3+ 4+ 
Protein(mg/dl) 0 10 30 100 300 
 
1000 
 
  
Routine haematological investigations were noted.  
Clinical examination was done at each visit along with weight gain, blood pressure 
and protienuria. 
Ultrasound scan was done at 12 to 14 weeks and 20 to 26 weeks.  
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Based on the following high risk factors, the women were categorized into two 
groups—high risk and low risk19. 
• H/o chronic hypertension  
• Diabetes 
• Renal disease 
• Obesity (BMI >30); 
• Age<20 or>35 years (in primigravida) 
• Past bad obstetric history of—preeclampsia, intrauterine growth restriction, 
and intrauterine fetal demise. 
• Family h/o preeclampsia or IUGR in mother or sister. 
INCLUSION CRITERIA:  
• All pregnancies with correct LMP 
• Patients who gave informed written consent. 
EXCLUSION CRITERIA:  
• Patients who did not give consent 
• Multiple pregnancy 
• Anomalous foetus. 
Sequential uterine artery Doppler recordings were taken at 12 to 14 weeks and 20 to 
26 weeks of gestation. The woman was examined in a semi recumbent position after 
10 minutes of bed rest under real time ultrasonography using volusionGEmachine 
with frequency of 2- 5 MHz.Transabdominally, the probe was placed longitudinally in 
the lower lateral quadrant of the abdomen, angled medially. Color flow mapping is 
useful to identify the uterine artery as it is seen crossing the external iliac artery. The 
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sample volume was placed 1 cm downstream from this crossover point. In a small 
proportion of cases if the uterine artery branches before the intersection of the 
external iliac artery, the sample volume should be placed on the artery just before the 
uterine artery bifurcation. The same process is repeated for the contralateral uterine 
artery. With advancing gestational age, the uterus usually undergoes dextrorotation. 
Thus, the left uterine artery does not run as lateral as does the right21. 
Impaired uterine artery flow was considered in the following. 
• Persistent diastolic notch- unilateral or bilateral in the main uterine artery. An 
early diastolic notch is defined as a V shaped deflection towards the baseline 
in early diastole. 
• Elevated mean PI > 1.6 
• Both of the above. 
All pregnant women under study were carefully followed up regularly and her blood 
pressure, weight gain, fundal height was measured and urinary protein analysis was 
done at each antenatal visit. The patient was followed up till delivery and the outcome 
was noted with respect to the gestational age at delivery, birth weight and the 
perinatal events. 
The pulsatility index is defined as a measure of the variability of blood velocity in a 
vessel equal to the difference between the peak systolic and minimum diastolic 
velocities divided by the mean velocity during the cardiac cycle. Pulsatility index is 
an arterial blood-flow velocity waveform index designed to quantify the pulsatility or 
oscillations of the waveform. 
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PI is calculated with the aid of software installed on the ultrasound machine using 
the following formula: 
Pulsatility index = (Vmax-Vmin)/Vmaxmean. 
 
Where Vmax is the peak  systolic velocity, Vmin is the minimum forward diastolic 
velocity in unidirectional flow, or the maximum negative velocity in diastolic flow 
reversal, and Vmax mean is the maximum velocity averaged over (at least) one cardiac 
cycle. 
 
Table 5: Showing pulsatility index by Gomez et.al 
 
Gestational age 1sttrimester(Pl) 2ndtrimester(Pl) 3rd   trimester(Pl) 
5thcentile 1.1 0.7 0.6 
50thcentile 1.7 1.0 0.8 
95thcentile 2.7 1.5 1.2 
 
The above table shows the Pl values for the 5th, 50thand 95thcentiles for the 
different gestational ages. Ideally as gestation increases the pulsatility index 
should decrease. 
 
 
FIGURE: 19 Showing pulsatility index at different gestational age 
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METHODS FOR STATISTICAL ANALYSIS 
Demographic data of the included women is presented as descriptive statistics using 
range, mean and standard deviation for metric data and range, median and 
interquartile range for discrete data.  
Data were analysed using SPSS version 20 for windows. Frequency distribution of 
category variables were computed and Chis square test for proportions were used to 
analyse PI values and notching positivity with clinical preeclampsia or no 
preeclampsia& IUGR. Sensitivity, specificity, positive predictive value, negative 
predictive values were determined for both PI and notching in 1st and second 
trimesters. Notching and preeclamsia was also correlated with IUGR.  
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FIGURE: 20  :ULTRASOUND MACHINE GE VOLUSION 730 USED IN THIS STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE: 21 –Different probes. 
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OBSERVATIONS AND RESULTS 
In this prospective study a total of 280 pregnant women were recruited, however 
30 participants had to be excluded from the final analysis due to the following 
reasons: 
1) Did not return for follow up scans 
2) Pregnancy outcomes were not available. 
Records of 250 participants were available for the final analysis due small sample size 
did not allow for regression models could not be used and instead cross tabulations 
were employed. Out of these 250 women 55 women belong to high risk group and rest 
of 195 women belong to low risk group according to the risk factors already 
mentioned.55(22.5%) and 195(78%) were in high risk and low risk groups 
respectively. 
BASELINE OBSTETRIC ANDDEMOGRAPHIC CHARACTERISTICS 
Table: 6- Baseline obstetric and demographic data 
DATA N = 250 MEAN ± STANDARD DEVIATION 
Age range(years)  
 
18-29 
 
30-34 
35-39 
40+ 
 
170 (68%) 
 
24 (20%) 
14 (12%) 
1 (1%) 
 
27.0 
 
± 5.42 
Parity 
 
1st  pregnancy  
 
2nd  pregnancy  
 
3rd  pregnancy 
 
4th pregnancy 
 
 
87 (35%) 
65(26%) 
52 (21%) 
45(18%) 
 
NIA 
N/A 
 As shown in table 6, it can be seen that  majority of participants, 170 (68%)were in 
the age group 18 - 29, while 24 (20%) were between 30 and 34 years of age, and 14 
(12%) were older than 35 years of age, with the mean age being 27.0 (±SD 5.42).
Parity : 87 (35%) patients it was their first pregnancy while 
65(26%) were  gravida 2,52 
BLOOD PRESSURE
The systolic blood pressure (mean±SD
The diastolic blood pressure (mean±SD
The mean systolic and diastolic blood pressure of 
graph . 
GRAPH
HIGH RISK FACTORS 
Various high risk factors and the associated risk of preeclampsia was studied like age,
maternal history of chronic hypertension, diabetes, renal disease
history and family history was taken into account as these factors have been seen to 
be associated with the higher incidence o
 
0 20
SBP
DBP
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 (21%) gravida 3 and 45(18%) gravida 4.
 
) was 131.62±12.74  
) was 87.62±10.67. 
the population is represented in the 
- 1. Mean systolic and diastolic blood pressure.
,
f preeclampsia and is shown in T
 
87.62
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TABLE-7.Distribution of various risk factors in the high risk group and the 
association between various risk factors and development of preeclampsia 
Risk factors No. of women (55) Preeclampsia 
Age <20 13 3(19%) 
Age>35 6 2(36%) 
h/o chronic hypertension 7 5(60%) 
h/o diabetes 2 0 
h/o chronic renal disease - - 
Past h/o preeclampsia, 
IUGR, IUFD 
27 10(38%) 
 
 
COMPLICATIONS 
The women in study group developed various complications associated with the 
decreased uteroplacental blood flow, the most important being preeclampsia. 
48(19.2%).The incidence of IUGR were 68(27%).The rate of still birth and early 
neonatal death were 2(0.8%),4(1.6%) in respectively which was statistically not 
significant as there were other causative factors like birth asphyxia, congenital 
anomalies contributing significantly for the perinatal mortality  in the low risk group. 
The incidence of oligohydramnios was 5(2%) of women developing oligohydramnios 
as shown in  Table 9 and Graph 6. 
TABLE – 8 Various complications in the study group 
Complications in  the study group 
Preeclampsia 48(19%) 
IUGR 68(27%) 
Still birth 2(0.8%) 
Early neonatal death 4(1.6%) 
Oligohydramnios 5(2%) 
 Graph 
PREGNANCY INDUCED 
Among the 55 high risk patients, 16
Gestational hypertension
in 3(15%),12(75%). 
TABLE 9
Complication
Gestational hypertension
Mild preeclampsia
Severe preeclampsia
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2: Various complications in the study group.
HYPERTENSION. 
 developed pregnancy induced hypertension. 
 was seen in 2(2%) and mild, severe preeclampsia 
. Severity of pregnancy induced hypertension
 HR  PIH 
 
2(12%) 
 
3(18%) 
 
11(75%) 
 
 
was seen 
 
 Graph 3-.showing types of pregnancy induced hypertension
 
PREDICTIVE VALUE
PREECLAMPSIA  
UTERINE ARTERY DOPPLER
 
Uterine artery Doppler screening was performed in the 1
pregnancy for each patient to assess its sensitivity in predicting PET &
Table 10: UTERINE ARTERY DOPPLER PULSATILITY INDICES 
 
DEPENDAN
T VARIABLE 
Uterine artery PI 
1st trimester 
2nd trimester 
 
The above table demonstrates the mean pulsatility index (Pl) for each trimester.
 
 
64 
 OF UTERINE ARTERY DOPPLER
 SCREENING 
nd
 and 
(CURRENT STUDY) 
NUMBER RANGE 
DEVIATION
250 
 
(0.6-2.9) ±0.47
250 (0.5-2.3) ±0.33
 
 
 
 FOR 
2nd trimester of 
IUGR 
±STD 
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Table 11 UTERINE ARTERY DOPPLER SPECTRAL WAVEFORM 
ANALYSIS 
 
 
 
Participants with notching decreased from 70 in the 1st trimester to 48 in the 2nd 
trimester. The majority of participants (72%-in the 1st 1rimester), (76%-in the 2nd 
trimester) had a uterine artery spectral waveform which displayed no notching, in 
keeping with normal trophoblast invasion of the maternal spiral arteries. 
 
PREGNANCY OUTCOME: 
32   pregnant women delivered before 37 week  of gestation and rest of 198 pregnant 
women  delivered between 37 to 42 weeks of gestation. 
TABLE 12: PREGNANCY OUTCOMES 
OUTCOME N =250 
Gestational age at delivery  
32(14%) <37 weeks 
37 - 42 weeks 198(80%) 
>42 weeks 0 
Birth weight 
 
68(27%) <2500g 
>2500g 182 (72%) 
Developed PET 48 (19.2%) 
Intrauterine fetal death 2(0.8%) 
DEPENDANT VARIABLE NUMBER 
Notching (1sttrimester) N=250 
Yes 
No 
70(28%) 
180 (72%) 
Notching (2nd trimester) N=250 
Yes 
No 
48 (23%) 
202 (76%) 
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Babies weighing less than 2500 g at term were considered small for gestational age, 
whereas fetal growth restriction (FGR) implies that a fetus has not achieved its 
optimal growth potential. 
 
PI  FIRST TRIMESTER 
  
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Valid NEGATIVE 164 65.6 65.6 65.6 
PI POSITIVE 86 34.4 34.4 100.0 
Total 250 100.0 100.0  
Interpretation: 86  women out of 250 women shows  pulsatility index above cutoff 
value in first trimester and 164 women had PI within normal range. 
 
NOTCHING  FIRST TRIMESTER 
 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid NEGATIVE 180 72.0 72.0 72.0 
POSITIVE 70 28.0 28.0 100.0 
Total 250 100.0 100.0  
 
Interpretation: 70  women out of 250 women shows  diastolic notching in first 
trimester and 180 women had no diastolic notching. 
 
PI  SECOND TRIMESTER 
 
 Frequency Percent Valid Percent Cumulativ
e Percent 
Valid PI NEGATIVE 174 69.6 69.6 69.6 
PI POSITIVE 76 30.4 30.4 100.0 
Total 250 100.0 100.0  
 
Interpretation: 76  women out of 250 women shows  pulsatility index above cutoff 
value in second trimester and 174 women had PI within normal range. 
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NOTCHING SECOND TRIMESTER 
 
 Frequency Percent Valid Percent Cumulative Percent 
Valid NEGATIVE 192 76.8 76.8 76.8 
POSITIVE 58 23.2 23.2 100.0 
Total 250 100.0 100.0  
Interpretation: 58  women out of 250 women shows  diastolic notching in second 
trimester and 192 women had no diastolic notching. 
 
PREECLAMPSIA 
 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid NO PREECLAMPSIA 202 80.8 80.8 80.8 
PREECLAMPSIA 48 19.2 19.2 100.0 
Total 250 100.0 100.0  
Interpretation: 48 women out of 250 women had developed preeclampsia and 202 
women had no evidence of preeclampsia. 
 
IUGR  
 
 Frequency Percent Valid Percent Cumulative Percent 
Valid NO IUGR 182 72.8 72.8 72.8 
IUGR POSITIVE 68 27.2 27.2 100.0 
Total 250 100.0 100.0  
 
Interpretation: 68  fetus had developed IUGR out of 250 birth remaining 182 foetus  
had no evidence of IUGR. 
 
Association between Notching  in 1st trimester and  preeclampsia 
 
40% of patients who had notching in 1st trimester had significantly higher 
preeclampsia while 88.9% of them who did not have notching had no preeclampsia 
(χ2=27.1, p<0.001)  
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Association between Notching  in1st trimester and  preeclampsia Cross tabulation 
 
  PREECLAMPSIA CAT 
Total    NO 
PREECLAMPSIA 
PREECLAMPSIA 
NOTCAT1 NEGATIVE Count 160 20 180 
Expected Count 145.4 34.6 180.0 
% within NOTCAT1 88.9% 11.1% 100.0% 
% within 
PREECLAMPSIACAT 
79.2% 41.7% 72.0% 
% of Total 64.0% 8.0% 72.0% 
POSITIVE Count 42 28 70 
Expected Count 56.6 13.4 70.0 
% within NOTCAT1 60.0% 40.0% 100.0% 
% within 
PREECLAMPSIACAT 
20.8% 58.3% 28.0% 
% of Total 16.8% 11.2% 28.0% 
Total Count 202 48 250 
Expected Count 202.0 48.0 250.0 
% within NOTCAT1 80.8% 19.2% 100.0% 
% within 
PREECLAMPSIACAT 
100.0% 100.0% 100.0% 
% of Total 80.8% 19.2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 27.113a 1 .000   
Continuity Correctionb 25.283 1 .000   
Likelihood Ratio 24.754 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
27.005 1 .000 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 13.44. 
b. Computed only for a 2x2 table 
69 
 
 
 
Sensitivity of notching was only 58% (95% CI between 43% and 72%) while 
specificity was 79% (95% CI between 72% and 84%.The positive predictive value 
was 40% and negative predictive value was 88%. 
 
Condition 
Totals 
 
 Absent  Present 
 Test Positive  42 28 70 
 Test Negative  160 20 180 
 Totals  202 48 250 
 
 
 
 
NOTCHING FIRST TRIMESTER 
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Estimated 
Value 
95% Confidence Interval 
 
Lower Limit Upper Limit 
Prevalence 0.192 0.146204 0.247495 
Sensitivity 0.583333 0.432754 0.720676 
Specificity 0.792079 0.728257 0.844524 
For any particular test result, the probability that it will be: 
Positive 0.28 0.226144 0.340752 
Negative 0.72 0.659248 0.773856 
For any particular positive test result, the probability that it is: 
True Positive 0.4 0.286898 0.524136 
False Positive 0.6 0.475864 0.713102 
For any particular negative test result, the probability that it is: 
True Negative 0.888889 0.831419 0.929149 
False Negative 0.111111 0.070851 0.168581 
likelihood Ratios: 
   [C] = conventional          [W] = weighted by prevalence 
Positive [C] 2.805556 1.957342 4.021342 
Negative [C] 0.526042 0.375443 0.737049 
Positive [W] 0.666667 0.472231 0.941159 
Negative [W] 0.125 0.082579 0.189212 
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Association between Notching 2nd trimester and   pre-eclampsia 
Notching was positive in 65.5% of patients with preeclampsia and negative in 94.8% 
of patients without preeclampsia (χ2=104.4, p<0.001) 
          NOTCHING 2ND TRIMESTER VS PREECLAMPSIA Cross tabulation 
  
 PREECLAMPSIACAT 
Total 
  
 
NO 
PREECLAMP
SIA 
PREECLA
MPSIA 
NOTCAT
2 
NEGATIVE Count 182 10 192 
Expected Count 155.1 36.9 192.0 
% within NOTCAT2 94.8% 5.2% 100.0% 
% within 
PREECLAMPSIACAT 
90.1% 20.8% 76.8% 
% of Total 72.8% 4.0% 76.8% 
POSITIVE Count 20 38 58 
Expected Count 46.9 11.1 58.0 
% within NOTCAT2 34.5% 65.5% 100.0% 
% within 
PREECLAMPSIACAT 
9.9% 79.2% 23.2% 
% of Total 8.0% 15.2% 23.2% 
Total Count 202 48 250 
Expected Count 202.0 48.0 250.0 
% within NOTCAT2 80.8% 19.2% 100.0% 
% within 
PREECLAMPSIACAT 
100.0% 100.0% 100.0% 
% of Total 80.8% 19.2% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 104.433a 1 .000   
Continuity Correctionb 100.582 1 .000   
Likelihood Ratio 91.261 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
104.016 1 .000 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 11.14. 
b. Computed only for a 2x2 table 
 
 
NOTCHING II TRIMESTER 
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Sensitivity of notching in 2nd trimester was 79% (95% CI between 64% and 89%) 
while specificity was 90% (95% CI between8 4% and 93%). The positive predictive 
value was 65% and negative predictive value 94%. 
 
 
Condition 
Totals 
 
 Absent  Present 
 Test Positive  20 38 58 
 Test Negative  182 10 192 
 Totals  202 48 250 
 
 
 Estimated 
Value 
95% Confidence Interval 
 
Lower Limit Upper Limit 
Prevalence 0.192 0.146204 0.247495 
Sensitivity 0.791667 0.645963 0.890442 
Specificity 0.90099 0.849161 0.936976 
For any particular test result, the probability that it will be: 
Positive 0.232 0.182155 0.290263 
Negative 0.768 0.709737 0.817845 
For any particular positive test result, the probability that it is: 
True Positive 0.655172 0.517957 0.771798 
False Positive 0.344828 0.228202 0.482043 
For any particular negative test result, the probability that it is: 
True Negative 0.947917 0.903557 0.973316 
False Negative 0.052083 0.026684 0.096443 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 7.995833 5.146593 12.42246 
Negative [C] 0.231227 0.133069 0.401791 
Positive [W] 1.9 1.272497 2.836943 
Negative [W] 0.054945 0.030034 0.100518 
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Association between PI  first trimester and preeclampsia 
PI was above cutoff in 23.3% of patients with preeclampsia and below cutoff  in 
82.9% of patients without preeclampsia though not significant (χ2=1.39, p=0.24)  
 
                PI 1ST TRIMESTER VS PREECLAMPSIA Cross tabulation 
  
 PREECLAMPSIA CAT 
Total    NO 
PREECLAMPSIA 
PREECLAMPSIA 
PICAT1 NEGATIVE Count 136 28 164 
Expected Count 132.5 31.5 164.0 
% within PICAT1 82.9% 17.1% 100.0% 
% within 
PREECLAMPSIACAT 
67.3% 58.3% 65.6% 
% of Total 54.4% 11.2% 65.6% 
PI POSITIVE Count 66 20 86 
Expected Count 69.5 16.5 86.0 
% within PICAT1 76.7% 23.3% 100.0% 
% within 
PREECLAMPSIACAT 
32.7% 41.7% 34.4% 
% of Total 26.4% 8.0% 34.4% 
Total Count 202 48 250 
Expected Count 202.0 48.0 250.0 
% within PICAT1 80.8% 19.2% 100.0% 
% within 
PREECLAMPSIACAT 
100.0% 100.0% 100.0% 
% of Total 80.8% 19.2% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 1.390a 1 .238   
Continuity Correctionb 1.020 1 .312   
Likelihood Ratio 1.360 1 .243   
Fisher's Exact Test    .242 .156 
Linear-by-Linear 
Association 
1.385 1 .239 
  
N of Valid Cases 250     
 
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 16.51. 
b. Computed only for a 2x2 table 
 
 
Sensitivity of  PI in1st trimester was 41% (95% CI between 27% and 56%) while 
specificity was 67% (95% CI between 60% and 73%). The positive predictive value 
was 65% and negative predictive value 94%. 
PI FIRST TRIMESTER 
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Condition 
Total 
 
 Absent  Present 
 Test Positive  66 20 86 
 Test Negative  136 28 164 
 Totals  202 48 250 
 
 
 
 Estimated 
Value 
95% Confidence Interval 
 
Lower Limit Upper Limit 
Prevalence 0.192 0.146204 0.247495 
Sensitivity 0.416667 0.279324 0.567246 
Specificity 0.673267 0.603329 0.736493 
For any particular test result, the probability that it will be: 
Positive 0.344 0.285985 0.406895 
Negative 0.656 0.593105 0.714015 
For any particular positive test result, the probability that it is: 
True Positive 0.232558 0.151059 0.338373 
False Positive 0.767442 0.661627 0.848941 
For any particular negative test result, the probability that it is: 
True Negative 0.829268 0.760944 0.881739 
False Negative 0.170732 0.118261 0.239056 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 1.275253 0.864385 1.881418 
Negative [C] 0.866422 0.678967 1.10563 
Positive [W] 0.30303 0.202889 0.452599 
Negative [W] 0.205882 0.146576 0.289185 
 
 
  
77 
 
Association between PI  2nd trimester and preeclampsia 
PI was above cutoff in 23.7% of patients with preeclampsia and below cutoff  in 
82.8% of patients without preeclampsia though not significant (χ2=1.41, p=0.23)  
 
 
Association between PI  2nd trimester and preeclampsia Crosstabulation 
   PREECLAMPSIA CAT 
Total    NO 
PREECLAMPSIA 
PREECLAMPSIA 
PICAT2 PI NEGATIVE Count 144 30 174 
Expected Count 140.6 33.4 174.0 
% within PICAT2 82.8% 17.2% 100.0% 
% within 
PREECLAMPSIACAT 
71.3% 62.5% 69.6% 
% of Total 57.6% 12.0% 69.6% 
PI POSITIVE Count 58 18 76 
Expected Count 61.4 14.6 76.0 
% within PICAT2 76.3% 23.7% 100.0% 
% within 
PREECLAMPSIACAT 
28.7% 37.5% 30.4% 
% of Total 23.2% 7.2% 30.4% 
Total Count 202 48 250 
Expected Count 202.0 48.0 250.0 
% within PICAT2 80.8% 19.2% 100.0% 
% within 
PREECLAMPSIACAT 
100.0% 100.0% 100.0% 
% of Total 80.8% 19.2% 100.0% 
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Chi-Square Tests 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 1.415a 1 .234   
Continuity Correctionb 1.031 1 .310   
Likelihood Ratio 1.375 1 .241   
Fisher's Exact Test    .295 .155 
Linear-by-Linear 
Association 
1.410 1 .235 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 14.59. 
b. Computed only for a 2x2 table 
 
 
 
Interpretation: Using Pearson Chi-square test it is found that PI is significantly 
associated with Pre-eclampsia. 
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Sensitivity of PI  in 2nd trimester was 37% (95% CI between 24% and 52%) while 
specificity was 71% (95% CI between 64% and 77%). The positive predictive value 
was 23% and negative predictive value 83%. 
 
 
Condition 
Total 
 
 Absent  Present 
 Test Positive  58 18 76 
 Test Negative  144 30 174 
 Totals  202 48 250 
 
 Estimated 
Value 
95% Confidence Interval 
 
Lower Limit Upper Limit 
Prevalence 0.192 0.146204 0.247495 
Sensitivity 0.375 0.243214 0.526663 
Specificity 0.712871 0.644382 0.773103 
For any particular test result, the probability that it will be: 
Positive 0.304 0.248437 0.365702 
Negative 0.696 0.634298 0.751563 
For any particular positive test result, the probability that it is: 
True Positive 0.236842 0.149988 0.350704 
False Positive 0.763158 0.649296 0.850012 
For any particular negative test result, the probability that it is: 
True Negative 0.827586 0.76138 0.878929 
False Negative 0.172414 0.121071 0.23862 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 1.306034 0.853873 1.997635 
Negative [C] 0.876736 0.701463 1.095805 
Positive [W] 0.310345 0.20339 0.473542 
Negative [W] 0.208333 0.150094 0.289171 
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Association between Notching and IUGR 
70.7% who had notching had no IUGR and 26.6% without notching had IUGR 
(χ2=0.17, p=0.68) 
 
Association between Notching and IUGR Crosstabulation 
 IUGR CAT 
Total NO IUGR 
IUGR 
POSITIVE 
NOTCAT2 NEGATIVE Count 141 51 192 
Expected Count 139.8 52.2 192.0 
% within 
NOTCAT2 
73.4% 26.6% 100.0% 
% within IUGR 
CAT 
77.5% 75.0% 76.8% 
% of Total 56.4% 20.4% 76.8% 
POSITIVE Count 41 17 58 
Expected Count 42.2 15.8 58.0 
% within 
NOTCAT2 
70.7% 29.3% 100.0% 
% within IUGR 
CAT 
22.5% 25.0% 23.2% 
% of Total 16.4% 6.8% 23.2% 
Total Count 182 68 250 
Expected Count 182.0 68.0 250.0 
% within 
NOTCAT2 
72.8% 27.2% 100.0% 
% within IUGR 
CAT 
100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square .170a 1 .680   
Continuity Correctionb .059 1 .807   
Likelihood Ratio .168 1 .682   
Fisher's Exact Test    .737 .399 
Linear-by-Linear 
Association 
.169 1 .681 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 15.78. 
b. Computed only for a 2x2 table 
 
 
 
 
The sensitivity of notching with IUGR was poor at 25% and specificity was 77%) 
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Condition 
Total 
 
 Absent  Present 
 Test Positive  41 17 58 
 Test Negative  141 51 192 
 Totals  182 68 250 
 
 
 
Estimated 
Value 
95% Confidence Interval 
Lower Limit Upper Limit 
Prevalence 0.272 0.218755 0.332393 
Sensitivity 0.25 0.156329 0.372248 
Specificity 0.774725 0.705774 0.831813 
For any particular test result, the probability that it will be: 
Positive 0.232 0.182155 0.290263 
Negative 0.768 0.709737 0.817845 
For any particular positive test result, the probability that it is: 
True Positive 0.293103 0.18463 0.429102 
False Positive 0.706897 0.570898 0.81537 
For any particular negative test result, the probability that it is: 
True Negative 0.734375 0.665009 0.794168 
False Negative 0.265625 0.205832 0.334991 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 1.109756 0.678509 1.815096 
Negative [C] 0.968085 0.841313 1.11396 
Positive [W] 0.414634 0.269006 0.639099 
Negative [W] 0.361702 0.284843 0.4593 
 
Diastolic notch is not significantly associated with IUGR. 
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Association between PI in first trimester and IUGR 
PI  FRIST TRIMESTER VS  IUGR Crosstabulation 
  IUGR CAT 
Total 
 
NO IUGR 
IUGR 
POSITIVE 
PICAT1 NEGATIVE Count 130 34 164 
Expected Count 119.4 44.6 164.0 
% within PICAT1 79.3% 20.7% 100.0% 
% within IUGR CAT 71.4% 50.0% 65.6% 
% of Total 52.0% 13.6% 65.6% 
PI POSITIVE Count 52 34 86 
Expected Count 62.6 23.4 86.0 
% within PICAT1 60.5% 39.5% 100.0% 
% within IUGR CAT 28.6% 50.0% 34.4% 
% of Total 20.8% 13.6% 34.4% 
Total Count 182 68 250 
Expected Count 182.0 68.0 250.0 
% within PICAT1 72.8% 27.2% 100.0% 
% within IUGR CAT 100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. 
Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 10.073a 1 .002   
Continuity Correctionb 9.146 1 .002   
Likelihood Ratio 9.788 1 .002   
Fisher's Exact Test    .003 .001 
Linear-by-Linear 
Association 
10.033 1 .002 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 23.39. 
b. Computed only for a 2x2 table 
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Condition 
Total 
 
Absent Present 
 Test Positive  52 34 86 
 Test Negative  130 34 164 
 Totals  182 68 250 
 
 Estimated 
Value 
95% Confidence Interval 
 
Lower Limit Upper Limit 
Prevalence 0.272 0.218755 0.332393 
Sensitivity 0.5 0.377433 0.622567 
Specificity 0.714286 0.641884 0.777463 
For any particular test result, the probability that it will be: 
Positive 0.344 0.285985 0.406895 
Negative 0.656 0.593105 0.714015 
For any particular positive test result, the probability that it is: 
True Positive 0.395349 0.293312 0.506827 
False Positive 0.604651 0.493173 0.706688 
For any particular negative test result, the probability that it is: 
True Negative 0.792683 0.720991 0.850331 
False Negative 0.207317 0.149669 0.279009 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 1.75 1.257433 2.435517 
Negative [C] 0.7 0.549546 0.891645 
Positive [W] 0.653846 0.478467 0.893509 
Negative [W] 0.261538 0.19329 0.353885 
PI FIRST TRIMESTER 
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Association between PI in second trimester and IUGR 
Association between PI in second trimester and IUGR Crosstabulation 
   IUGR CAT 
Total 
   
NO IUGR 
IUGR 
POSITIVE 
PICAT2 PI NEGATIVE Count 135 39 174 
Expected Count 126.7 47.3 174.0 
% within PICAT2 77.6% 22.4% 100.0% 
% within IUGR CAT 74.2% 57.4% 69.6% 
% of Total 54.0% 15.6% 69.6% 
PI POSITIVE Count 47 29 76 
Expected Count 55.3 20.7 76.0 
% within PICAT2 61.8% 38.2% 100.0% 
% within IUGR CAT 25.8% 42.6% 30.4% 
% of Total 18.8% 11.6% 30.4% 
Total Count 182 68 250 
Expected Count 182.0 68.0 250.0 
% within PICAT2 72.8% 27.2% 100.0% 
% within IUGR CAT 100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact 
Sig.  
(1-sided) 
Pearson Chi-Square 6.622a 1 .010   
Continuity Correctionb 5.850 1 .016   
Likelihood Ratio 6.395 1 .011   
Fisher's Exact Test    .013 .009 
Linear-by-Linear 
Association 
6.595 1 .010 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 20.67. 
b. Computed only for a 2x2 table 
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Condition 
Total 
 
 Absent  Present 
 Test Positive  47 29 76 
 Test Negative  135 39 174 
 Totals  182 68 250 
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Estimated 
Value 
95% Confidence Interval 
Lower Limit Upper Limit 
Prevalence 0.272 0.218755 0.332393 
Sensitivity 0.426471 0.309264 0.552019 
Specificity 0.741758 0.670736 0.80236 
For any particular test result, the probability that it will be: 
Positive 0.304 0.248437 0.365702 
Negative 0.696 0.634298 0.751563 
For any particular positive test result, the probability that it is: 
True Positive 0.381579 0.274653 0.500569 
False Positive 0.618421 0.499431 0.725347 
For any particular negative test result, the probability that it is: 
True Negative 0.775862 0.705244 0.834018 
False Negative 0.224138 0.165982 0.294756 
likelihood Ratios: 
   [C] = conventional 
   [W] = weighted by prevalence 
Positive [C] 1.651439 1.141172 2.389869 
Negative [C] 0.773203 0.627558 0.952648 
Positive [W] 0.617021 0.4408 0.863691 
Negative [W] 0.288889 0.218403 0.382122 
 
Severe IUGR is best predicted in second trimester by increased pulsatility index 
(positive likelihood ratio1.65, negative likelihood ratio 0.77(CI 0.62-0.95). 
 
 
 
 
 
 
88 
 
Association between Preeclampsia and IUGR 
50% of patients with preeclampsia had IUGR while 21.8% of patients without 
preeclampsia had IUGR (χ2=15.6, P<0.001) 
 
ASSOCIATION BETWEEN PREECLAMPSIA AND IUGR CROSS TABULATION 
   IUGR  
Total    NO 
IUGR 
IUGR 
POSITIVE 
PREECLAMPSIA NO   
PREECLAMPSIA 
Count 158 44 202 
Expected Count 147.1 54.9 202.0 
% within 
PREECLAMPSIACAT 
78.2% 21.8% 100.0% 
% within IUGR CAT 86.8% 64.7% 80.8% 
% of Total 63.2% 17.6% 80.8% 
PREECLAMPSIA Count 24 24 48 
Expected Count 34.9 13.1 48.0 
% within 
PREECLAMPSIACAT 
50.0% 50.0% 100.0% 
% within IUGR CAT 13.2% 35.3% 19.2% 
% of Total 9.6% 9.6% 19.2% 
Total Count 182 68 250 
Expected Count 182.0 68.0 250.0 
% within 
PREECLAMPSIACAT 
72.8% 27.2% 100.0% 
% within IUGR CAT 100.0% 100.0% 100.0% 
% of Total 72.8% 27.2% 100.0% 
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Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 15.595a 1 .000   
Continuity Correctionb 14.203 1 .000   
Likelihood Ratio 14.325 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
15.533 1 .000 
  
N of Valid Cases 250     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 13.06. 
b. Computed only for a 2x2 table 
 
 
Interpretation: Using Pearson Chi-square test it is found that Preeclampsia is 
significantly associated with IUGR at 0.001 level of significance. 
 
PREECLAMPSIA 
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Using pulsatility index >1.6 and diastolic notch as the abnormal Doppler study the 
predictive value of the test was calculated. 
In the first trimester screening 70(28%) patients had diastolic notching on Doppler 
study of which 28 patients developed preeclampsia &remaining 42 patients even 
though had notching had no preeclampsia.  In 180 patients without diastolic notching 
on Doppler, 20 developed preeclampsia. In 86 patients who had PI>2.3, 20 patients 
developed preeclampsia and 66 patients had no preeclampsia even though PI was 
above 50th centile level. The sensitivity, specificity, positive and negative predictive 
value, positive and negative likelihood ratios for the abnormal test using uterine artery 
notching and PI>2.3 were 58%, 79%,40%, 88%,4.02 and 0.73 respectively and 
41%,67%, 65%,94%,1.8 and 1.1 respectively. 
In the second trimester screening 58(23%) patients had diastolic notching on Doppler 
study of which 38 patients developed preeclampsia remaining 20 patients even though 
had notching had no preeclampsia .  In 192 patients without diastolic notching on 
Doppler, 10 developed preeclampsia. In 76 patients who had PI>1.6 , 18 patients  
developed preeclampsia  and 58 patients  had no preeclampsia even  though PI was 
above cut off level. The sensitivity, specificity, positive and negative predictive value, 
positive and negative likelihood ratios for the abnormal test using uterine artery 
notching and PI>1.6 were 79%, 90%,65%, 94%,12.4 and 0.4 respectively and 
37%,71%, 23%,83%,0.8 and 0.2 respectively. 
The relative risk of development of preeclampsia with abnormal uterine artery 
Doppler in the HR and LR group were 3.482 and 3.158 respectively with the p value 
of <0.0001 which is statistically significant 
 
 Proportion of patients developing preeclampsia with normal and abnormal uterine 
artery Doppler in first trimester.
Proportion of patients developing preeclampsia with normal and abnormal 
arterydoppler in second trimester.
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TABLE-13.Relative risk of developing preeclampsia in abnormal uterine artery 
Doppler velocimetry using PI. 
  P value Level of 
significance 
High risk 5.094  95%CI 2.423-16.15 <0.0001 Significant 
Low risk 
7.071 
 95% CI4.268-
15.41 
<0.0001 Significant 
 
BIRTH WEIGHT 
The mean ±SD of birth weight in high and low risk group  was 2.522±0.655 kg and 
2.730±0.467 kg with the t value of 2.2856 and p value of 0.0234 which was 
statistically significant as  given in  Table 18 and in  Graph 14. 
TABLE- 14. Mean birth weight in HR and LR group. 
 
HR LR T value P value 
Statistical 
significance 
Birth weight 
(kg) 
2.522±0.655 2.730±0.467 2.2856 0.0234 Significant 
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DISCUSSION 
The findings of this study will be summarized in this chapter so that conclusions 
can be drawn on the sensitivity of uterine artery Doppler screening in predicting 
preeclampsia and fetal growth restriction. 
Pre-eclampsia is the most common pregnancy complication associated with serious 
maternal-fetal morbidity and mortality. At present the only effective treatment is 
delivery of the placenta. Uterine artery Doppler waveforms can identify women 
with obstetric complications related to abnormal placentation, since Doppler 
ultrasonography is a useful method to assess the velocity of uterine artery blood 
flow. An abnormal velocity waveform is characterised by a high resistance to flow 
and or an early diastolic notch. Early screening for pre-eclampsia by uterine artery 
Doppler has been suggested based on the concept that the pathogenic mechanisms 
of pre-eclampsia may be modified if prophylactic therapies are initiated early in 
pregnancy (Herraiz 2009 : 1123). 
Abnormal uterine artery Doppler waveforms are also able to identify foetuses at 
high risk of preterm delivery and low birth weight (Ghidini2008 : 259). 
Pregnancies complicated by FGR warrant close surveillance for maternal and fetal 
complications and interventions in anticipation of a preterm delivery due to an 
apparent high risk for the development of pre-eclampsia (Mitaniet al., 2009 : 886). 
It is hypothesised that the ability to predict those women at risk for pre-eclampsia 
early in pregnancy might decrease maternal and fetal morbidity through closer 
surveillance programmes. 
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The purpose of this study was to assess the sensitivity of uterine artery Doppler 
screening in predicting pre-eclampsia and FGR before the onset of the disease. The 
Results of this study could be used to evaluate whether it is worthwhile 
implementing a routine screening program for pre-eclampsia. 
 
In this prospective study First and second-trimester Doppler screening was carried out 
in 280 consecutive singleton pregnancies at 12-14 and 20-26 weeks of gestation We 
excluded 30 cases because they had missing outcome data. In the remaining 250 
pregnant women there were 48 (19.2%) pregnant who developed pre-eclampsia, 
including 11 (23%) in which delivery was before 34 weeks (early preeclampsia) and 
37 (76%) with delivery at 34 weeks or later (late pre-eclampsia), 6(2.3%) who 
developed gestational hypertension, 68(27%) who delivered IUGR. This was slightly 
higher than the various other studies which showed a higher incidence of IUGR 
associated with abnormal Doppler values and also significantly higher in the high risk 
group. In the study by Bhattacharya et al, incidence of IUGR was 36.54%. In various 
other studies the incidence of preeclampsia was ranging from 8.18% to39.2%.The 
tests used to predict preeclampsia include clinical history, examination findings, 
laboratory and hemodynamic tests. In general, tests in early pregnancy for predicting 
later development of preeclampsia have better specificity than sensitivity as alpha 
fetoprotein, fibronectin and uterine artery Doppler (bilateral notching) all have 
specificities above 90%.Only uterine artery Doppler pulsatility index and 
combinations of indices have a sensitivity of over 60%.In other such similar studies, 
various demographic factors were studied and the predictive value of the uterine 
artery Doppler was also studied. 
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MATERNAL AGE  
Preeclampsia is more common in extremes of age group. Pregnant women below 20 
years and above 35 years are at an increased risk, and in the latter group preeclampsia 
superimposed on chronic hypertension is seen. In our study majority (89%) of the 
patients who developed PET were between the ages of 18 and 34 years, 3(19%) 
patients were <20 years & 2 (36%) patients was >35years  out of the 48 pregnant  
who developed pre-eclampsia Data suggests that the risk of pre-eclampsia increases 
by 30% for every additional year over the age of 34. In our study age, therefore, did 
not play a role as a risk factor for PET 
PARITY 
 
Pre-eclampsia is twice as common in primi gravid women as compared to women 
for whom it is their second or more pregnancy . Women with pre-eclampsia are 
therefore twice as likely to be nulliparous as women without preeclampsia. In 
DuGkitts study (2005:2) nulliparity almost triples the risk for developing pre-
eclampsia. In our study, 12 (25%) patients out of the 48 who developed pre-
eclampsia were primigravida, thus indicating that gravidity was not a strong 
predisposing factor for the disease. 
BLOOD PRESSURE 
The mean systolic blood pressure in the in the third trimester of pregnancy was 
131.62±12.74 mmHg. The diastolic blood pressure (mean±SD) was 87.62±10.67 
mmHg. The raised blood pressure in preeclampsia is due to release of placental anti 
angiogenic factors and other factors  which causes maternal endothelial cell 
activation/ endothelial dysfunction. 
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BIRTH WEIGHT 
The mean ±standard deviation of birth weight was 2.522±0.655kg. In the study by 
Bhattacharya et al,mean birth weight was 2.25±0.58kg. Many studies show a lower 
birth weight in high risk patients with abnormal uterine artery Doppler studies26, 36. In 
our study since more number of high risk patients had abnormal uterine artery 
Doppler and subsequently intrauterine growth restriction, the birth weight had a 
statistically significant p value. 
UTERINE ARTERY DOPPLER WAVEFORM ANALYSIS 
 
Uterine artery Doppler waveforms were performed to assess uteroplacental 
circulation in the first and second trimester in all participants. A series of screening 
studies involving assessment of impedance to flow in the uterine arteries, have 
examined the potential value of doppler assessment in identifying pregnancies at 
risk of complications due to impaired placentation. 
Increased impedance to flow in the uterine arteries in pregnancies attending routine 
antenatal care identifies about 50% of those patients that subsequently develop 
preeclampsia and it identifies about 30% of those patients that subsequently 
develop FGR. Shear and colleagues (2005: 1119) reported a relationship between 
pre-eclampsia and FGR. Their study showed critical maternal complications more 
frequently in pre-eclamptic patients with associated FGR. 
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The current study assessed the sensitivity of Pl and diastole notching as a 
diagnostic tool to predict pre-eclampsia and IUGR. 33 out of the 48 patients who 
developed pre-eclampsia had abnormal Doppler waveforms which were evident 
from as early as the first trimester. The study therefore demonstrated that an 
abnormal uterine artery waveform with early diastolic notching could predict 58% 
of cases that developed PET from as early as the 1st trimester. What is however 
significant is that uterine artery waveform, analysis was able to predict PET in the 
most severe cases in patients who presented with early manifestations of the 
disease and had the worst pregnancy outcomes. 
Pl VALUES 
 
A study done by Melchiorre (2008: 135) reported that uterine artery Doppler 
indices were significantly higher in women who developed preterm pre-
eclampsia. 
In the current study Pl values up to the 95th1 centile of the Pl chart was considered 
as normal. The following table was populated with data obtained from a study 
done by Gomez and co workers(2000 :130). 
TABLE 15 UTERINE ARTERY DOPPLER INDICES 
 
Gomez et al 1st trimester (Pl) 2"n trimester (Pl) 
5th  centile 1.1 0.7 
50th  centile 1.7 1.0 
95th  centile 2.7 1.5 
 
These values represent the 50thcentile for each of the trimesters of pregnancy at 
12 weeks and 22 weeks of gestation and are also used as cut off values by the 
Fetal Medicine Unit at Chris Hani Baragwanath Hospital in ,Johannesburg 
(Nicolaou, 2011). 
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Table 16.UTERINE ARTERY DOPPLER  INDICES (50thcentile-current 
study) 
 
Current study 1st trimester (Pl) 2ndtrimester (Pl) 
50thcentile 1.3 0.9 
 
Comparing the mean values in our study to the mean values in the study done by 
Gomez and colleagues, a difference in the mean (50thcentile) in the 1st trimester is 
noted. The 2nd trimester mean values in this study were similar to the values obtained 
by Gomez et al. In both studies it can be seen that the mean Pl values decreased as 
gestation increased as is to be expected in a normal pregnancy. 
In our study the 1st trimester Pl values in patients who developed pre-eclampsia was 
not a strong predictor of PET. None of the values recorded were above the 95th 
centile when compared to the values by Gomez and co-workers. However, in clinical 
practice a 1st trimester Pl value of >1.5 is deemed as elevated and warrants 
monitoring (Nicolaou, 2011: Personal communication). In the group that developed 
PET, 1st trimester Pl values ranged between 0.9 and 1.75 respectively. It is thus 
evident that only in selected cases an increased resistance to flow was recorded in the 
1st trimester. 
In the 2nd trimester most of PET cases hada Pl value above the 50th centile 
signifying that Pl performed better as a predictor of PET in the 2nd trimester. 
 
Comparing the mean Pl values in the patients who developed pre-eclampsia to the 
mean Pl values developed by Gomez et al., only 6out of 20 cases were  recorded 
values were on the 50thcentile in the 1st trimester, while 12 out of 18  2nd trimester 
values were above the 50thcentile. Doppler Pl values obtained in this study were above 
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the 50th centile. a few patients had increased Pl values of who most were marginally 
elevated. 
Predictive value of uterine artery Doppler 
 In our study when the predictive value of PI in1st trimester was evaluated, the 
sensitivity and specificity were 41% and 67% respectively in the 1st trimester which 
was similar to the studies by Coleman et al and Caforio et al. The positive and negative 
predictive value was similar to the study by Cnossens et al, the positive and negative 
likelihood ratios were similar to other studies by Chien et al and our study had negative 
likelihood ratio of 1.2 and positive likelihood ratio of 0.8, P-0.24. Our study also gives 
the higher sensitivity and specificity compared to other studies  
TABLE- 17. Various studies showing predictive value of the uterine artery 
Doppler using PI in 1st trimester. 
 
Type of 
study 
Sample 
size 
Sensi 
tivity% Specificity Ppv Npv Plr Nlr 
Present study 
Cnossen  et al 
Prospective 
Prospective 
 
250 
4966 
41 
25 
 
67 
95 
 
65 
- 
 
 
94 
- 
 
1.2 
5.4 
 
0.8 
0.78 
It was found that mean PI in the first trimester had reduced statistical significance  in 
detecting preeclampsia .This is consistent with the findings of another study by martin 
et al and holis, who have shown an unchanged PI throughout the 11-14 weeks 
interval, but gomez et al demonstrated a lower impedance in the uterine artery of 
normal outcome pregnancy than in complicated cases suggesting lack of a normal 
uteroplacental circulation at this early stage of pregnancy may predict the later 
development of some pregnancy complications. The existing data suggest that 
increased impedance to flow in the uterine arteries identify about 25% of those who 
subsequently develop preeclampsia. 
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In 2nd trimester, the sensitivity and specificity for the uterine artery pulsatility index 
were 37% and 71% using PI>1.6 as the abnormal Doppler study criteria which was 
similar to the studies by Cnossens et al. In other studies by Papageorghiouet al and 
Ratanasiri et al, the sensitivity and specificity was higher compared to the present 
study. The present study has the positive and negative predictive value similar to 
studies by Bhattacharya et al and Ratanasiri et al. The positive and negative likelihood 
ratio of the present study were 1.99 and 1.09 which was similar to the study by 
Cnossens et al, Jimmy Espinoza et al and Chien et al, but Ratanasiri et al showed a 
higher positive likelihood ratio implicating better predictive value of the test as shown 
in Table.  
TABLE-18.Various studies showing predictive value of the uterine artery 
Doppler using PI in 2nd trimester. 
 Type of study Sample 
size 
Sensitivity Specificity Ppv Npv Plr Nlr 
Prajapati et al Prospective  200 30.30 94.01 50 87.22 5.06 
(2.29, 
11.18) 
0.74 
(0.59, 
0.93) 
Jimmy 
Espinoza et al 
Prospective 4190 33.3 90.5 11 97.5 3.49 0.74 
Pongrojpaw et 
al 
Prospective 330 59.25 65.60 - - - - 
Cnossen JS et 
al 
Systematic 
review 
351 19 99 - - 21 0.82 
Present study Prospective 250 37 
 
71 
 
23 
 
83 
 
 1.99 
 
1.0 
 
 
The predictive value of the uterine artery was more when pulsatility index was used 
with a higher sensitivity, specificity, predictive value, higher positive likelihood ratio 
and lower negative likelihood ratio. Also, the relative risk was higher when pulsatility 
index was used. Various studies have proved a higher predictive value of uterine 
artery Doppler study for preeclampsia and other adverse pregnancy outcomes when 
pulsatility index is used as seen in the present study also. 
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Swanepoel (2004:6) suggested that the presence of notch is a significantly better 
predictor of poor pregnancy outcome than the pulsatility index; however, in other 
studies the presence of notching in the 2nd  trimester in a low risk population has been 
associated with a high probability for developing FGR and preeclampsia. In high-risk 
pregnancies the risk increases up to 60% (Hernandez-Andrade et al., 2002: 441). It 
has been established that uterine artery notching that persist after 26 weeks of 
gestation be considered a risk factor for poor pregnancy outcomes (Andrarleet al., 
2002 : 440). An early diastolic was found to persist in 25-40% of cases after 26 weeks 
gestation (Swanepoel: 2004:6) 
 
In our study the presence of notching in the second trimester was the best predictor 
for the development of pre-eclampsia.  
Uterine artery Doppler analysis in the high risk population has shown potential for 
predicting adverse pregnancy outcomes (Harrington et al., 2004: 50). 
The results of our study confirm the work done by Pilalis (2007 : 533) and 
Harrington (2004:54) who both found that second trimester uterine artery Doppler 
screening has proven to be a sensitive and accurate tool for predicting pre-eclampsia 
and fetal growth restriction in high risk populations. 
In 1st trimester, the sensitivity and specificity for the uterine artery diastolic notch 
were 58 and 79% as the abnormal Doppler study criteria which was lower to the 
studies by Cnossens et al. The positive and negative likelihood ratio of the present 
study were 2.8 and 0.5 which was higher to the study by Cnossens et al, Jimmy 
Espinoza et al and Albaiges G et al.  
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In 2nd   trimester, the sensitivity and specificity for the uterine artery diastolic notch 
were 79 and 90% as the abnormal Doppler study criteria which was similar to the 
studies by Cnossens et al. The positive and negative likelihood ratio of the present 
study were 4 and 1.09 which was also similar to the study by Cnossens et al, Jimmy 
Espinoza et al and Chien et al.  
We found that 151 trimester notching persisted into the 2nd trimester in (23)43% 
patients who developed pre-eclampsia. The presence of notching, even with a 
normal Pl index, places the patient at a higher risk for adverse fetal outcomes. 
 
The findings of our study thus concur with the findings by Mcleod (2009:728) who 
states that the presence of an early diastolic notch is associated with adverse 
pregnancy outcomes. Our study also supports the findings of Kurdi (1998:344) who 
found that women with notching represent a group with an increased risk of 
developing complications, in particular those that require early delivery. 
PREGNANCY OUTCOMES IN THE STUDY POPULATION 
 
In the current study 80% of the population delivered at term, and 72% of the 
population delivered babies weighing more than 2500g. 19%patients developed 
pre-eclampsia, and 2 patient who developed pre-eclampsia had an IUFD at twenty 
eight weeks gestation.  
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CROSS TABULATIONS IN LOW BIRTHWEIGHT BABIES 
Cross tabulations were done on low birth weight babies using notching in the first 
&second trimesters as predictors for FGR. Notching in the second trimester was 
once again the best predictor. Mothers with notching in the second trimester are 
six(6) times more likely to deliver a low birth weight baby than mothers with no 
notching in the second trimester. 
Intrauterine growth restriction in low-risk patients was best predicted in the second 
trimester by an increased pulsatility index with notching (positive likelihood ratio 1.6, 
95% CI –1.1 -2.3; negative likelihood ratio 0.77, 95% CI 0.62–0.95).  
ASSOCIATION BETWEEN PREECLAMPSIA AND IUGR 
It has been proved beyond doubt, in the previous studies and in the present study that 
preeclampsia is significantly associated with IUGR. The sensitivity in the present 
study of finding IUGR in patients with preeclampsia was 50% and specificity was 
21%. This proves that both these entities preeclampsia and IUGR, stems from a 
common pathophysiology which has been known to be early defective placentation. 
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SUMMARY 
Preeclampsia is a pregnancy specific disorder of unknown aetiology accounting for 
14% of maternal deaths worldwide. Incidence of this disorder is around 8-10%. 
Uterine artery Doppler screening meets all the requirements of a worthwhile 
screening program in prediction of preeclampsia. Uterine artery screening at 22 to 24 
weeks gestation is superior to first trimester screening in prediction of preeclampsia 
and other adverse pregnancy outcomes. Despite these impressive results, few 
hospitals have established uterine artery screening programs in the second trimester as 
there is no effective preventive therapy when treatment is commenced after 24 weeks 
and also patients may develop adverse pregnancy outcome before 24 weeks gestation. 
A study was conducted in our hospital to know the predictive value of uterine artery 
Doppler to 14 weeks and 24 to 26 weeks gestation using diastolic notching and 
pulsatility index as the abnormal test results in both the high risk and low risk groups. 
The results showed that abnormal uterine artery Doppler had a good predictive value 
in predicting women who developed preeclampsia, more so in the high risk group and 
that pulsatility index is a better Doppler index in the prediction of preeclampsia. This 
was in accordance to various other studies. 
Doppler ultrasound is anon-invasive and reliable method for prediction of 
preeclampsia and adverse pregnancy outcome, but currently there are no effective 
interventions to prevent adverse outcomes based on an abnormal result. Studies are 
needed to find out such an intervention. Until such time, routine uterine artery 
Doppler screening of women is not required. Only screening in high risk women will 
suffice as to be more cautious during the pregnancy.  
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CONCLUSION 
Preeclampsia accounts for 10% of perinatal mortality and 14% of maternal mortality 
and morbidity. Early recognition of women of preeclampsia will help in identifying 
high risk women who may benefit from early prophylaxis &enhanced surveillance.  
Abnormal uterine artery Doppler studies in the first and second trimester have been 
associated with subsequent adverse pregnancy outcomes including preeclampsia, fetal 
growth restriction, and perinatal mortality. 
Mid trimester uterine artery Doppler velocimetry can be used as a reliable screening 
test for prediction of preeclampsia especially in the high risk group and it helps to 
reduce maternal and fetal complications by elective delivery.  
Increased pulsatility index with notching in second trimester predicted overall 
preeclampsia in high risk and low risk patients, increased pulsatility index or bilateral 
notching predicted severe preeclampsia.   However the prediction is of not much use 
as there are no effective pharmacological treatment in preventing preeclampsia and 
other complications. As this is a small study, the usefulness of the uterine artery 
Doppler study has to be evaluated using a large cohort. 
Pre-eclampsia is significantly associated with IUGR in the low risk population. 
The mean PI cut-off which can differentiate patients who develop pre-eclampsia and 
IUGR was >1.6 in second trimester.  
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PROFORMA 
I. Particulars of the patient: 
1. Name 
2. Age 
3. Occupation 
4. Address 
5. Phone number 
II. History: 
1. Duration of amenorrhea 
2. Any history of high risk factors: 
 
 
a. Age <20 years 
b. Age> 35 years 
c. H/o diabetes 
d. H/o chronic hypertension 
e. H/o chronic renal disease 
f. Past bad obstetric history of preeclampsia, 
iugr and iufd 
g. Family history of preeclampsia/ iugr 
 
III. Obstetric history: married life, consanguinity, obstetric index, history of 
present pregnancy 
IV. Menstrual history: previous cycles, regularity, last menstrual period (LMP), 
estimated date of delivery(EDD) and period of gestation. 
 
V. Investigations 
• Haemoglobin 
• Urine albumin 
• Urine routine 
• Ultrasonography at  16 to 18 weeks:  
Single/multiple: 
Gestational age: 
EDD  according to scan: 
Any fetal anomalies: 
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VI. Category of the patient: high risk / low risk 
 
VII. Uterine artery doppler ultrasonography at 12 to 14 weks and at 24 to 26 
weeks: 
• Diastolic notch:    present/ absent    unilateral/ bilateral 
• Pulsatality index:   right                        left 
 NORMAL/ ABNORMAL 
VIII. Follow up chart: 
Date Gestational age Any complaints BP Urinary protien USG findings 
      
 
 
IX. Outcome: 
• Mode of delivery: vaginal/caesarean/instrumental 
• Gestational age at delivery: preterm/term/postterm 
• Any comlications: abruption/imminent symptoms/eclampsia/IUGR/still birth 
• Perinatal  outcome: birth weight/NICU admission 
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INFORMATION SHEET 
 
 We are conducting a study on “First Trimester and Midtrimester Uterine 
Artery Doppler Sonography in Predicting Preeclampsia and IUGR” your 
participation in the study is very valuable to us. 
 
 The purpose of this study is to find out whether First Trimester and 
Midtrimester Uterine Artery Doppler Sonography changes is significant in 
predicting preeclampsia and IUGR in pregnant women. 
 
 We will do Uterine Artery Doppler Sonography  in pregnant women between 
12-14 weeks and 20-26 weeks. 
 
 The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not 
result in any loss of benefits to which you are otherwise entitled.  
 
 The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment.  
 
Signature of investigator    Signature of participant 
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INFORMED CONSENT FORM 
Title: “First Trimester and Midtrimester Uterine Artery Doppler Sonography in 
Predicting Preeclampsia and IUGR” 
Name of the investigator: Dr. PRIEYA DHARSHINI.J 
Name of the participant: 
Name of the institution: Govt. Kasturba Gandhi Hospital & Institute of obstetrics and 
gynaecology, MMC, Chennai. 
 
                  I ___________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am 
over 18 years of age and exercising my power of choice, hereby give my consent to 
be included as a participant in this study. 
1. I have read and understood this consent form and the information provided to me. 
2. I have read the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained my rights and responsibilities by the invigilator, 
5. I have informed the investigator of all the treatments I am taking or have taken in 
the past months/years including any native treatments 
6. I have been advised about the risks associated with my participation in the study 
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms. 
8. I have not participated in any research study within the past. 
9.I am aware of the fact that I can opt out of the study at any time without having to 
give any reason. This will not affect my future treatment in the hospital. 
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10. I am also aware that the investigators may terminate my participation in this study 
at any time, for any reason, without my consent. 
11. I hereby give permission to the investigators to release the information obtained 
from me as result of participation in this study to the sponsors, regularity authorities, 
Govt. agency and IEC if required. 
12. I understand that my identity will be kept confidential if my data are publicly 
presented. 
13. I have had my questions answered to my satisfaction. 
14. I consent voluntarily to participate in the research/study 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form, I attest that the information given in this 
document has been clearly explained to me and understood by me. I will be given a 
copy of this consent document. 
FOR ADULT PARTICIPANTS 
1. Name and signature /thumb impression of the participant(or legal 
representative if participant incompetent) 
Name_______________ Signature_________________ Date____________ 
 
2. Name and signature of impartial witness(required for illiterate patients) 
Name______________ Signature ________________Date____________ 
 
3. Name and signature of the investigator or his representative obtaining consent 
Name_____________ Signature_______________ Date__________ 
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 ெபய: டா(ட. ெஜ. ப8யதஷின
 
பேகபாள8 ெபய: 
நிவன-தி ெபய: மகேபறிய# ம ெபேணாயய# நிவன, எ.எ.சி, ெசைன. 
                         நா ___________________ இ+த ப5வ-தி# தகவைல ப5-தி(கிேற (அ#ல அ 
என() ப5(க ப;4ள). நா எ+த ேகவகைள7 ேக;க தயகவ#ைல, அைவ 
அைன-தி) பதி# கிைட-த. நா 18 வயதி) ேம# இ(கிேற, ேத ெசய எ 
ஆறைல பயப4-கிேற, இ+த ஆவ# பேகபாளராக ேச(கபட எ அ@மதியைன 
அள
(கிேற. 
1. இ+த ஒ%த# ப5வ-ைத7 என() வழகப;ட தகவைல7 நா வாசி- %8+ 
ெகாேட. 
2. ஒ%த# ஆவண-ைத நா ப5-தி(கிேற. 
3. ஆவ தைம பறி நா வள(கப;4ேள. 
4. என உ8ைமக ம ெபா%க பறி நா வள(கப;4ேள. 
5. கட+த சில மாதகள
# நா எ4() அைன- சிகி2ைசக'() %லவசாரைண 
அறிவ-தி(கிேற 
6. ஆவ# எ பகள
%ட ெதாட%ைடய அபாயக பறி நா அறி-தப;5(கிேற 
7. நா %லனாவாளட ஒ-ைழ(க ஒ-(ெகாகிேற ம நா அசாதாரண 
அறி)றிகைள அ@பவ-தா# உடன5யாக அவைர / அவ'() ெத8வேப. 
8. கட+த கால-தி) நா எ+த ஆரா2சிய< பேககவ#ைல. 
9. எ+த ேநர-தி< எ+தெவா காரண-திகாக நா இ+த ஆவ#  இ+  வலகி( 
ெகாள  .57 எபைத நா அறி+தி(கிேற. இ எ எதிகால சிகி2ைசைய 
ம-வமைனய# பாதி(கா எபைத7  அறி+தி(கிேற. 
10. எ+தெவா காரண-திகாக, எ அ@மதியறி ஆவாள எ பேகைப ந=(க .57 
எபைத அறி+தி(கிேற. 
11. இ+த ஆவ# பேகபாளகளான, ஆவாளக அர> நிவன ம IEC ஆகியவறி) 
ேதைவப;டா#, என
டமி+ ெபறப;ட தகவைல ெவள
யட %லனா() அ@மதி 
அள
-ேத. 
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12. என தர பகிரகமாக வழகப;டா#, என அைடயாள-ைத ரகசியமாக ைவ-திபைத 
நா %8+ெகாகிேற. 
13. எ திதி() எ ேகவக'()  பதி# அள
(கப;ட. 
14. ஆரா2சி / ஆகள
# பேகக நா தனாவ-ட ஒ%(ெகாகிேற 
இ+த ஆவ ேபா என() ஏதாவ ேகவக இ+தா#, நா %லனாவாளைர 
ெதாட% ெகாள ேவ4 எ என() ெத87. இ+த ஒ%த<(கான ப5வ-ைத 
ைகெயாபமி4வத Aல, இ+த ஆவண-தி# ெகா4(கப;ட தகவ#க ெதள
வாக என() 
வள(கப;4 என() %8+வ;ட எபைத நா சாறள
(கிேற. இ+த ஒ%த# 
ஆவண-தி நகைல என() வழகப4. 
பழ)5 வ)பாளக'() 
பேகபாள8 ெபய ம ைகெயாப / க;ைடவர# உணைவ (அ#ல பேகபாள 
த)தியறவ என
# ச;ட பரதிநிதி) 
 
ெபய_______________ ைகெயாப ______________ ேததி _________ 
 
பாரப;சமற சா;சிய ெபய ம ைகெயாப (ப5பறிவற ேநாயாள
க'() ேதைவ) 
 
ெபய______________ ைகெயாப ________________DATE____________ 
 
%லவசாரைண அ#ல அவர பரதிநிதி அ@மதிப-திர-தி ெபய ம ைகெயாப 
 
ெபய_____________ ைகெயாப ___________ ேததி _______ 
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KEY TO MASTER CHART 
 
GA- gestational age at 
delivery(weeks) 
Sbp- systolic blood pressure 
Dbp- diastolic blood pressure 
C-caesarean delivery 
N- normal delivery 
In-instrumental delivery 
Sp- severe preeclampsia 
Mp- mild preeclampsia 
Gh- gestational hypertension 
Ie- imminent eclampsia 
Ape- antepartum eclampsia 
Iugr-intrauterine growth 
restriction 
Abr- abruption 
Oligo-oligohydramnios 
L-live birth 
D- still birth 
BW-birth weight in gms 
n- no NICU admission 
y- NICU admission 
 
SN- serial no. 
BMI- body mass index kg/m2 
Gra- gravidity 
m- multigravida 
p- primigravida 
H-high risk 
L- low risk 
UAD- uterine artery Doppler 
DN+/- : diastolic notching 
Rt- right side 
Lt – left side 
Pi- pulsatality index 
N- normal 
 
 
